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 Blood vessels are the primary means by which blood is transported to the body. 
Blood carries oxygen and nutrients which are delivered to tissues in order to maintain 
tissue viability and homeostasis.   Endothelial cells line the vessel wall and prevent blood 
clot formation.  Neovascularization, formation of new blood vessels or vasculature, of 
tissue engineered substitutes is imperative for successful implantation into sites of injury.  
Strategies to promote vascularization within tissue engineered constructs have focused on 
1) incorporating endothelial or endothelial progenitor cells within the construct and 2) 
treating the constructs with angiogenic factors such as VEGF or FGF.  While these 
strategies have shown some improvement in vascularization of tissue engineered 
substitutes, some challenges still remain.  Diffusion of soluble angiogenic factors 
becomes inhibited in tissue engineered constructs which have multiple cell layers and 
exceed 100 μm in thickness.  Additionally, since endothelial (ECs) and endothelial 
progenitor cells EPC are adult cell types, acquiring quantities of cells needed for 
regenerative medicine applications is not feasible due to diminishing availability of 
endothelial sources in patient populations.  Stem cells have been explored as a cell source 
for tissue engineered substitutes for a multitude of regenerative medicine therapies due to 
their inherent ability to differentiate into all somatic cell types.  While stem cells can give 
rise to a number of cell types, such as ECs, methods to better control their differentiation 
need to be explored.  Current EC differentiation strategies require laborious and extensive 
culture periods, utilize large quantities of growth factors and extracellular matrix, and 
generally yield heterogenous populations for which only small percentage of the 
differentiated cells are ECs.  Initial strategies to derive endothelial cells from stem cells 
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focused on 2D cultured in the presence of prescribed extracellular matrices and growth 
factors.  Differentiation in vivo occurs in a 3D microenvironment, which is in contrast to 
the 2D in vitro microenvironment used for 2D ESC EC differentiation strategies.  In 
order to recapitulate 3D ESC differentiation in vivo 3D aggregates or embryoid bodies 
(EBs) have been employed in vitro.  EBs can give rise to endoderm, endoderm, and 
mesoderm cell, including ECs.  Additionally, EBs recapitulate aspects of embryogensis, 
such as vasculogenesis and angiogensis.  Thus, the objective of this project was to 
examine the effects of pre-conditioning ESCs with fluid shear stress on EB endothelial 
differentiation and vasculogensis.  The overall hypothesis of this research is that exposing 
ESCs to in vivo vasculogenic cues will promote EB endothelial differentiation and 
vascologensis. 
 In the developing embryo fluid shear stress is an instructive cue for endothelial 
differentiation and vasculogenesis and has been explored as a means to differentiate 
ESCs into ECs.  Fluid shear stress can be applied to ESCs in a homogeneous manner in 
comparison to the use of cytokines and growth factors to promote ESC differentiation.  
The application of fluid shear stress at different magnitudes and profiles promotes stem 
cells to differentiate to ECs and hematopoietic cells.  While the acute effects of fluid 
shear stress on ESC-EC differentiation are well characterized, the extended effects of 
fluid shear stress on ESC-EC differentiation are unknown.  To examine the effects of 
fluid shear stress on ESCs, shear pre-conditioned (0, 5, or 15 dyn/cm2) ESCs were 
differentiated as EBs and then analyzed for endothelial and hematopoietic genes 
throughout EB differentiation.  Additionally, expression of endothelial and hematopoietic 
proteins and changes in EB morphology were investigated.   Endothelial gene expression 
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analysis displayed differences in endothelial gene expression profile in EBs formed from 
shear pre-conditioned ESCs and EBs formed from statically cultured ESCs.  Most 
notably, EBs formed from shear pre-conditioned ESCs developed a homogeneous 
morphology which was significantly different from the morphology observed in EBs 
formed from statically cultured ESCs.  Moreover, EBs formed from shear pre-
conditioned ESCs developed a central cluster of endothelial-like cells which expressed 
VE-cadherin and were observed throughout EB differentiation.  Presence of endothelial-
like cells within EBs formed from ESCs pre-conditioned with shear could be detected by 
centrally located dark regions observed through phase microscopy.  Overall, the results 
suggest that shear pre-conditioning ESCs prior to EB formation affected the organization 
and localization of endothelial-like cells within EBs and yielded populations of EBs 
which contained endothelial-like cells.   
 During embryogensis VEGF is important for endothelial differentiation, 
vasculogenis, and angiogenesis.  This angiogenic factor stimulates proliferation and 
migration of cells expressing VEGF receptors. Because of its importance in endothelial 
specification in vivo, VEGF has been consistently used to promote ESC EC 
differentiation.  Thus, in order to modulate differentiation and expansion of the 
endothelial-like clusters in EBs formed from shear pre-conditioned ESCs, EBs were 
treated with VEGF.  VEGF was delivered to EBs solubly or via release from 
microparticles.  Diffusion of growth factors into the EB microenvironment is limited due 
to tight cell junctions on the outer layer of the EB.  Therefore, microparticles which 
released VEGF were incorporated within the EB microenvironment to circumvent 
diffusion limitations.  Soluble VEGF treatment of EBs formed from shear pre-
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conditioned ESCs yielded EBs which were smaller in size in comparison to similar EBs 
which were not treated with VEGF.  Moreover, VEGF soluble treatment induced 
endothelial-like cells to localize to the outer layer of EBs formed from shear pre-
conditioned ESCs unlike untreated EBs which developed a cluster of endothelial-like 
cells at the center of EBs.  Endothelial–like cells clustered at the center of the EBs even 
in the presence of microparticles.  Endothelial marker gene expression analysis revealed 
significant increases in expression of  Flk-1, Flt-1, PECAM, and VE-cadherin in shear 
pre-conditioned EBs treated with soluble VEGF compared to shear pre-conditioned EBs 
not treated with VEGF, indicating that pre-conditioning ESCs with shear prior to VEGF 
treatment promotes endothelial differentiation.  Few differences in endothelial gene 
expression were detected between EBs treated with VEGF releasing microparticles and 
unloaded  microparticles.  VEGF treatment of EBs formed from ESCs cultured statically 
caused no change in EB endothelial marker gene expression.  Altogether these results, 
demonstrated that preconditioning ESCs with fluid shear stress elicited unique 
endothelial differential profile in the presence of VEGF.   Additionally, soluble treatment 
of VEGF elicited endothelial-like cells to organized on the outer layers of EBs.. 
 Oxygen gradients during embryogenesis regulate patterning and development of 
the vasculature.   Additionally, oxygen regulates endogenous production of angiogenic 
factors such as VEGF and transcription factor hypoxia inducible growth factors.  
Therefore, the effects of low oxygen on vasculogenesis within EBs formed from shear 
pre-conditioned ESCs were investigated.  EBs formed from pre-conditioned ESCs were 
cultured for 7 days under normoxic (21% O2) or under hypoxic (3% O2) conditions. 
Hypoxia culture of EBs elicited different EB morphology compared to EBs cultured 
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under normoxia, but low oxygen did not have any adverse effects on cell viability as 
demonstrated by LIVE/Dead staining.  Following 4 days of hypoxia culture EBs 
expressed similar levels of Flk-1, Flt-1, VE-cadherin, and PECAM compared to EBs 
cultured under normoxia.  After 7 days of hypoxia culture, endothelial marker genes were 
expressed at higher levels in all EB groups as compared to EBs cultured under normoxia.  
At day 7, endothelial- like cells in shear pre-conditioned EBs cultured under hypoxia 
organized into primitive vascular networks.  VEGF-A EB production results 
demonstrated that shear pre-conditioned EBs cultured under hypoxia produced the largest 
quantity of VEGF-A as compared to EBs cultured under normoxia as well as hypoxia 
EBs formed from statically cultured ESCs.  Gene expression analysis hypoxia inducible 
factor-A (HIF1α), a transcription factor regulated by oxygen levels, revealed no drastic 
changes in EB expression, however by day 7, HIF1α was expressed at similarly low 
levels in hypoxia EBs formed from statically cultured ESCs and hypoxia EBs formed 
from shear pre-conditioned EBs.  These studies demonstrated that hypoxia modulated EB 
endothelial differentiation, vasculogenesis, and angiogenic factor production.  Moreover, 
shear pre-conditioning ESCs prior to EB formation in conjunction with hypoxia may be a 
method to promote and control vasculogenesis within EBs. 
 In conclusion, this work has developed a method to pre-vascularize pluripotent 
stem cell aggregates which could be used for a multitude of tissue engineered substitutes 
for regenerative medicine applications.  A pluripotent stem cell aggregate which has 
primitive vasculature surrounded by cells which can be differentiated into 
cardiomyocytes, osteocytes, or beta-islets is an ideal template for developing cardiac, 
bone, or pancreatic tissues respectively.  Furthermore, these studies have revealed that 
xxiv 
priming ESCs with fluid shear stress prior to EB formation has subsequent effects on EB 
endothelial differentiation, endothelial cell-like organization and localization, angiogenic 
factor production, and vasculogenesis.  Future work will continue to explore strategies to 
engineer pre-vascularized EBs into tissues resembling in vivo organs.  Pre-vascularizaion 
of pluripotent stem cell aggregates have great utility in modular tissue engineering 







Tissue engineered products have been developed for a multitude of diseases and 
injuries ranging from cardiovascular [1, 2], spinal [3], pancreatic [4], skin [5] and 
orthopedic [6].  Many advancements in the field of tissue engineering have been made, 
few tissue engineering products have been approved by the FDA [5, 7], however major 
challenges still exist in order to create more engineered tissues that translate into the 
clinic.  One such challenge is vascularization of tissue engineered products, without 
proper vascularization tissue engineered products will not integrate with surrounding host 
tissue or remain viable. Researchers have investigated different strategies to promote 
vasculogenesis within tissue engineered products.  These strategies include adding 
angiogenic factors [8-10] and incorporating vascular cells such as endothelial cells or 
endothelial progenitor cells[ 11-13].  While these strategies have shown some promise, 
promoting vasculogenesis in tissue engineered products with complex architecture, 
multiple cell layers, and sizes that exceed optimal diffusion of nutrients have not been 
successful [14]. 
During embryonic development, vasculogenesis occurs in a well organized 
pattern that is spatially and temporally controlled by various cues and signals, such as 
fluid shear stress, hypoxia, and VEGF [15-19].  Fluid shear stress regulates 
cardiovascular gene and protein expression patterns in the embryo [17, 20].  Additionally, 
fluid shear stress imparted by blood flow is vital to the maturation and stabilization of the 
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primitive embryonic vasculature [21] and regulates arterial and venous specification, 
patterning of embryonic vessels [22] and eventual vessel size [23].  During 
embryogenesis, vasculogenesis and angiogenesis occur and diffusion of oxygen is 
inhibited due to embryo growth, causing an oxygen gradient throughout the embryo [18]. 
Hypoxia mediates temporal and spatial expression of VEGF receptors, Flk-1 and Flt-
1[24], and VEGF which are required for differentiation and organization of the vascular 
system [25].  In vivo, fluid shear stress, hypoxia, and VEGF are vital for the proper 
development of the vasculature system demonstrating the instructive potential of these 
cues and signals for development of vasculature in vitro. 
Embryonic development can be recapitulated in vitro in 3D aggregates of 
embryonic stem cells(ESCs) called embryoid bodies(EBs).  EBs can spontaneously 
differentiate and give rise to cells from all three germ layers: ectoderm, mesoderm, and 
endoderm[ 26-29].  Additionally, many morphogenic and developmental events, such as 
vasculogenesis can occur [30, 31].  However because differentiation is spontaneous there 
is great heterogeneity in EB populations in terms of the morphogenic events that the EBs 
are undergoing [32].  EBs can serve as an ideal template for a multitude of tissue 
engineered products due to their potential to give rise to cells of various tissues and 
ability to develop vascular networks.   Therefore, the objective of this work is to study 
the effects of fluid shear stress preconditioning of embryonic stem cells (ESCs) on 
embryoid body endothelial differentiation and vasculogenesis.  The central 
hypothesis is that exposing ESCs to fluid shear stress prior to EB differentiation will 
promote EB endothelial differentiation and vasculogensis.  The hypothesis was tested 
using the following three specific aims: 
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SpecificAim 1:  Evaluate the effects of preconditioning ESCs with fluid shear stress on 
subsequent embryoid body cardiovascular differentiation and morphogenesis. The 
working hypothesis is that fluid shear stress preconditioning alters ESC endothelial 
differentiation and morphogenesis.  A parallel plate flow chamber was used to apply 
varying magnitudes(5 and 15 dyn/cm2) of fluid shear stress to ESCs.  ESCs 
preconditioned with and without fluid shear stress were afterwards differentiated as EBs.  
Endothelial gene and protein expression was assessed after fluid shear stress 
preconditioning and during embryoid body culture, using qRT-PCR, immunostaining, 
and flow cytometry. 
Specific Aim 2:  Examine the effects of vascular endothelial growth factor (VEGF) on 
endothelial differentiation, endothelial-like cell organization, and vasculogenesis within 
embryoid bodies containing shear preconditioned ESCs.  The working hypothesis was 
that treating EBs with angiogenic factors will promote endothelial differentiation and 
endothelial-like cell organization within EBs.  VEGF was delivered to EBs solubly or by 
incorporating VEGF loaded gelatin microparticles within the EBs.  Vasculogenesis and 
endothelial-cell like organization were assessed through immunofluorescence of 
endothelial proteins and analyzed by confocal microscopy.  Quantitative real time PCR 
analysis of endothelial genes and western blots and flow cytometry analysis of 
endothelial proteins of single cells dissociated from EB samples were performed and 
compared to untreated EBs. 
Specific Aim 3:  Investigate the effects of hypoxia on vasculogenesis in EBs formed 
from shear pre-conditioned ESCs.  The working hypothesis was that hypoxia would 
promote formation of vascular networks in EBs formed from shear pre-conditioned 
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ESCs.  Following shear pre-conditioning, ESCs were differentiated as EBs under hypoxic 
conditions (1% O2) or normoxic conditions (21% O2) for 7 days.  Viability was assessed 
throughout EB differentiation and endothelial differentiation was assessed using qRT-
PCR, flow cytometry, and western blot.  Formation of vascular networks was assessed by 
whole-mount immunostaining of EBs for endothelial markers VE-cadherin and PECAM 
through confocal microscopy.  Additionally, expression of hypoxia inducible factors was 
assessed through western blot and qRT-PCR. 
 This work is innovative because it demonstrates that physical forces have 
prolonged effects on stem cell fate and differentiation potential.  Exposing pluripotent 
stem cells to fluid shear stress effects how they respond to environmental cues such as 
oxygen levels and VEGF.  Altogether this work will add to the knowledge base and 
understanding of the role of fluid shear stress on ESC differentiation within EBs.  This 
research provides insight into new strategies to promote ESC endothelial differentiatin.  
The expected outcome of this work is to gain a better understanding how physical forces 






The significant discovery of stem cells almost 5decades ago has created major 
advancements in regenerative medicine, cellular therapeutics, developmental biology, 
and stem cell biology.  Resident adult stem cells were initially identified in the bone 
marrow [33, 34],  and then later discovered in brain [35, 36], fat [37], muscle [38], and 
skin [39] tissues.  While several isolation, expansion, and differentiation protocols have 
been established for adult stem cells [39-41], they cannot be expanded to the quantities 
required for regenerative medicine applications.  Moreover, stem cells from adult tissues 
possess limited potency since their differentiation potential is limited by the tissue from 
which they were isolated.   
 
Embryonic Stem Cells 
Embryonic stem cells (ESCs) are derived from the inner cell mass of a blastocyst 
stage embryo [42, 43].  Due to their unique ability to give rise to cells comprising the 
three germ lineages: ectoderm, endoderm, mesoderm, [26-28, 44, 45].  ESCs have been 
examined as a potential cell source for  a wide variety of cells including but not limited to  
cardiomyocytes [46], neural cells [47], pancreatic cells [48], blood cells [49] and 
endothelial cells [50].   In order to obtain somatic cells from ESCs various differentiation 
strategies have been employed such as culturing ESCs in the presence of different 
cytokines, growth factors, and extracellular matrices [27].  However, ESCs can also be 
differentiated as 3D aggregates termed embryoid bodies (EBs).  EBs recapitulate aspects 
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of embryogenesis and allow for spontaneous differentiation in the three germ layers [26, 
32].  ESCs within EBs differentiate in response to stimuli such as cell-matrix interaction 
[51], cell-cell adhesions, cytokines [52], and growth factors [53], which are all 
microenvironmental stimuli present during embryonic development.  Because the EB 
microenvironment parallels the in vivo embryonic microenvironment more than 2D 
culture, ESC EB differentiation may be more effective in deriving somatic cells. 
 
Embryonic Stem Cells and Vascular Cell Differentiation 
Directed differentiation culturing methods have been established to derive 
endothelial cells (ECs) from ESCs [45, 50, 54-57].  The culturing methods generally 
involve the use of VEGF, collagen IV and collagen I, selection of Flk-1 positive cells, 
and multiple passaging procedures [50, 54-56].  The derivation of ECs from ESCs 
requires long culturing periods, large quantities of growth factors and extracellular 
matrix, which typically results in low cell yields.   
ESCs have the ability to differentiate into vascular cells in 3D culture.  EBs have 
been used to study vasculogenesis and angiogenesis [30, 31, 57, 58].  EBs recapitulate 
vasculogenesis and angiogenesis with the presence of immature hematopoeitic cells and 
endothelial cells [30, 31].  EBs which have been differentiated for 7 days contained 
populations of CD41 (hematopoietic) positive cells surrounded by channels and lumen 
lined with VE-Cadherin positive cells [31].  Although endothelial and hematopoietic 
differentiation can occur in EBs, the percentage of ESCs within the embryoid body which 
differentiate into endothelial and hematopoietic cells is less than 10% [31] and there is 
heterogeneity between EBs in terms of endothelial and hematopoietic differentiation 
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potential due to the complex nature of the EB microenvironment (matrix, cytokines, and 
growth factors).  The challenges associated with differentiating ESCs into vascular cells 
motivate the need to develop new methods to direct and enhance vascular cell 
differentiation. 
 
Endothelial and Hematopoietic Cell Development 
Endothelial and hematopoietic cells originate from mesoderm via a common 
precursor known as the hemangioblast [59, 60].  The hemangioblast is most notably 
defined by its expression of Flk-1 and SCL/Tal-1 genes [61, 62].  During early 
embryogenesis aggregates of hemangioblasts, in the extraembryonic yolk sac, mature and 
form blood islands which consists of an inner core of blood cells and an outer layer of 
endothelial cells[63].  The organization of hematopoietic and endothelial cells into blood 
islands initiates the onset of vascular development and expansion as blood island cells 
migrate, divide, and create connections to form the yolk sac vasculature[58].  Endothelial 
cells that develop from hemangioblast lose SCL/Tal-1 expression while hematopoietic 
cells lose Flk-1 expression.  By day 8 of development, aortic endothelial cells, expressing 
VE-Cadherin, CD34, PECAM, and Flk-1, have organized to form vessels [64].  
Hematopoietic cells, characterized by the expression of SCL/Tal-1, c-kit, Runx1, CD41, 




Fluid Shear Stress 
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 Fluid shear stress has been well studied and characterized in the vascular system .    
Within the vascular system shear stress spans a large range magnitudes and regimes 
(oscilatory, laminar, steady, tubrulent) and varies both spatially and temporally.  
Endothelial cells (ECs) which line the vasculature experience these shear stresses and 
respond to this physical force [66]. In vitro fluid shear studies have revealed that fluid 
shear stress modulates endothelial cell processes  such as  proliferation [67], cytoskeleton 
arrangement [68, 69], integrin expression [70], alignment [71], nitric oxide production, 
calcium signaling [72], as well as endothelial adhesion molecules such as vascular 
endothelial-cadherin (VE-cadherin) [73].  Somatic [71, 74] and stem cells [75-78] have 
been subjected to fluid shear stress at varying magnitudes and regimes in vitro using a 
number of bioreactor systems [71, 77, 79] for in vitro culture maintenance and cell 
generation as well as examination of fluid shear on cell phenotype.  In vitro fluid shear 
stress has been used as a method to recapitulate the in vivo fluid shear stress forces and 
study their cellular behavior in response to changes in this physical force. 
 
Fluid Shear Stress and Embryonic Stem Cells 
Embryonic stem cells have the ability to respond to fluid shear stress by changes 
in gene expression and cell proliferation [80].  Many researchers have demonstrated that 
fluid shear stress induces ESCs to differentiate towards vascular cells (endothelial cells 
and smooth muscle cells) [81-84].  ESCs exposed to pulsatile flow with resulting wall 
shear stresses of -0.98 to 2.2 dynes/cm2 demonstrated some endothelial function with the 
protein expression of PECAM1 and alignment in the direction of the pulsatile flow [84].  
Flk-1+ ESCs cultured under fluid shear stress of 1.5 and 5 dynes/cm2 display 
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significantly increased gene expression of endothelial specific markers such as Flk-1, Flt-
1, PECAM1, and VE-Cadherin [81].  Laminar shear stress of 10 dynes/cm2 increases 
smooth muscle cell and endothelial cell protein expression in ESCs.  ESCs exposed to 24 
hrs of laminar shear stress had increased protein expression of smooth muscle actin, 
monocyte enhancer factor-2c, and alpha sarcomeric actin, Flk-1,  eNOS[83].  Shear stress 
also induces ESCs to form tube-like structures in Matrigel™ or collagen I more readily 
than ESCs which have been cultured under static conditions [81, 83].  While such studies 
aimed to assess the effects of fluid shear stress on ESC endothelial differentiation, they 
are incomplete since these studies do not examine the prolonged effects of fluid shear 
stress pre-conditioning on ESC endothelial differentiation potential.  Additionally, the 
majority of these studies focus on magntidues lower than 15 dynes/cm2. 
  
Fluid Shear Stress and Vascular Progenitor Cells 
Fluid shear stress elicits phenotypic changes in ESC-derived endothelial cells, 
vascular progenitor cells, and hematopoietic progenitor cells [85-89].   ESC-derived 
endothelial cells respond similarly to fluid shear stress as mature endothelial cells 
respond to fluid shear stress with respect to changes in morphology, gene expression and 
protein expression.  ESC-derived endothelial cells elongate and orient in the direction of 
flow as do endothelial cells [86, 87].  In addition, shear stress induces similar changes in 
expression of monocyte chemotactic protein-1(MCP1), tissue plasminogen activator 
(tPA), matrix metalloproteinase-1 (MMP1), cyclooxygenase-2 (COX2), SOD2, and 
transforming growth factor β1 (TGFβ1) in ESC-derived endothelial cells and mature 
endothelial cells.  Furthermore, shear stress modulates gene transcription and expression 
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of CD31, ICAM1, and VE-Cadherin similarly in both cell types [87].  Zeng et al. 
determined that laminar flow increases proliferation of vascular progenitor cells(Sca1+ 
ESCs) and mRNA expression of PECAM1 (CD31), prominin1 (CD133),VE-Cadherin 
(CD144), VEGF receptor 1(Flt-1), and VEGF receptor 2(Flk-1) [85].  Hematopoietic 
progenitor or cKit+CD41+ ESCs show increased expression of Runx1, Myb, and 
Kruppel-life factor 2 (Klf2) and had increased frequency of colony formation after 
exposure to fluid shear stress.  These genes are associated with hematopoietic 
differentiation, vasculogenesis, and endothelial differentiation [89].  Daley et al. also 
demonstrated that shear stress can restore the hematopoietic progenitor cell population in 
mice embryos which lack the ability to initiate a heartbeat.  Overall, ESC-derived 
endothelial cells and vascular protegenitor cells and endothelial cells respond similarly to 
fluid shear stress. 
 
Vascular Endothelial Growth Factor 
Vascular endothelial growth factor (VEGF), a member of the platelet-derived 
growth factor family, (mouse 22-24kDa, human 45kDa), stimulates vasculogenesis and 
angiogenesis in response to low oxygen supply [90].  During embryonic development 
VEGF plays a major role in the creation of new blood vessels or vasculogenesis [15].  
Additionally, VEGF stimulates growth of blood vessels from pre-existing vessel, 
angiogenesis, following blood vessel damage[91].  Because VEGF has a primary role in 
vasculature development in vivo, VEGF has been used to differentiated stem cells to 
vascular cells and promote vasculogensisin vitro[50, 92, 93].   
 
11 
Vascular Endothelial Growth Factor and Development 
During development VEGF is imperative for proper development of the vascular 
system.  In vivo, loss of a single VEGF allele is lethal in mouse embryos because it leads 
to impaired angiogenesis and blood island formation [94]. When VEGF null ESCs are 
implanted into a blastocyst the developing embryo has defects in initial vasculature 
development as there is reduced yolk sac blood supply.  This leads to impairment in other 
developing organs such as unsegmented branchial arches and forelimbs, delayed 
development of the heart, and reduced number of nucleated blood cells within the yolk 
sac [95].   The detrimental effects which are caused by lack of VEGF during development 
clearly demonstrate the important role of VEGF in the initial development of the 
cardiovascular system, which supplies blood and nutrients to ensure proper formation of 
all organs and tissues. 
 
Vascular Endothelial Growth Factor and Endothelial Differentiation 
Angiogenesis and vasculogenesis each occur through migration and organization 
of endothelial cells (ECs).  Endothelial cells which express VEGF receptors, Flk-1 and 
Flt-1, produce VEGF [96] and respond to VEGF in a number of ways including survival, 
proliferation, migration, and angiogenesis [94, 97-99].  Therefore, VEGF has been used 
to derive ECs from stem cells.  Established ESC EC differentiation protocols all require 
VEGF treatment of ESCs in order to promote Flk-1 expression of ESCs and to continue 
to promote Flk-1+ ESCs to acquire EC phenotype [50, 54, 55].   Not only has VEGF 
been employed in 2D culture of ESCs, embryoid bodies treated with varying 
concentrations of VEGF (5-50ng/mL) yielded cells which expressed endothelial markers 
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CD31, VE-cadherin and vWF [50, 54].  These cells were able to form lumenized vessels 
in vitro and form networks of vessels containing host blood cells when implanted in 
infracted rate hearts [92].  Additionally, VEGF can promote ESC differentiation towards 
hematopoietic cells [100, 101].  VEGF stimulation of ESC monolayers induces 
formation of sac-like structures which consisted of endothelial and hematopoietic like 
cells [102].  Implanted hematopoietic stem cell survival is regulated by VEGF, VEGF 
gene ablation results in inability to home and implant at engraftment sites [103]. VEGF 
is critical for development, maintenance, and function of vascular cells. 
Hypoxia 
 Low oxygen or hypoxic conditions are present throughout many physiological 
environments, disease pathologies, and during embryonic development [19, 104-107].  
While cells are generally maintained and cultured at 21% oxygen (normoxic) in vitro, in 
vivo cells develop and function at oxygen levels are generally ranging from 1-10% 
(hypoxic) [19].  Oxygen levels play a very important role in many cellular processes 
including but not limited to metabolism, differentiation, proliferation, and tissue 
morphogenesis, [19, 108-110].  More specifically oxygen levels play a critical role in 
vascular development and differentiation during embryogenesis [19, 24, 111]. 
 
Hypoxia Inducible Factors 
Hypoxia inducible factors (HIFs) are transcription factors which are responsible 
for coordinating multiple processes which maintain homeostasis of O2 levels within 
mammals [112, 113].  HIFs are heterodimeric complexes which are made up of an alpha 
and beta subunit.  Under hypoxia HIF heterodimer complexes are stabilized and regulate 
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at least 180 genes) including VEGF, Flk-1, Flt-1, and Oct-4 [24, 112].  HIFs regulate 
transcription by binding to hypoxia response elements located on the promoter regions of 
their target genes [114, 115].  The HIF family is comprised of HIF-1, HIF-2, and HIF-3 
each having an alpha and beta subunit [116].  The alpha subunits are regulated by 
hypoxia, however the beta subunits are largely unresponsive to changes in O2 levels and 
affect O2 independent pathways [19, 116].  HIF-1α is universally expressed while HIF-2α 
is generally expressed to vasculature of early developing embryos, endothelial cells, 
neural crest derivative cells, lung type II pneumocytes, liver parenchuma, and kidney 
intestinal cells [117, 118]. HIF2α has been reported to regulate stem cell pluripotency and 
proliferation under hypoxic conditions [119, 120].Hypoxia mediates a multitude of 
cellular responses through stabilization of a family of transcription factors called HIFs, 
which are key regulators of many genes which play roles in a multitude of cellular 
processes.  
 
Hypoxia and Vascular Development 
 Oxygen levels regulate the development of a number of tissues including, but not 
limited to the tracheal, cardiovascular, placental, and skeletal systems (Simon, 2008 
#123).  Prior to the development of the circulatory system embryonic oxygen levels are 
approximately 3% O2 [114, 121].  Low oxygen tension is imperative for proper 
morphogenesis and function of the cardiovascular system in the early embryo [122].  
During cardiovascular development, the most critical and first system to develop within 
the embryo, vascular endothelial growth factor (VEGF) is produced by oxygen deprived 
cells [123, 124].  Lee et al. discovered spatial and temporal co-localization of HIF1α and 
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VEGF along with PECAM expressing cells forming vasculature and proliferating in 
hypoxic regions of the embryo [125].  Oxygen gradients within the embryo are critical 
for proper development and patterning of the vascular and cardiovascular systems. 
 
Hypoxia and Stem Cells 
 Low oxygen effects have been examined in a variety stem cell populations 
including pluripotent [111, 120, 126], mesenchymal [127-129], glioma [130] and 
hematopoietic [128].  Hypoxia regulates proliferation and differentiation [119, 131], as 
well as alters expression of genes responsible for survival, angiogenesis, and 
vasculogenesis [24, 120].  Furthermore, hypoxia pretreatment of stem cells has been 
explored as a means to improve stem cell survival and engraftment after transplantation 
into a number of diseased models [127, 132]. 
In pluripotent stem cells hypoxia (1-5% O2) downregulates the expression of 
pluripotency marker Oct4, while significantly upregulating angiogenic and vasculogenic 
markers VEGF and angiopoitein-like proteins.  Additionally, 50% hESCs cultured under 
5% O2 became CD34+ positive, an endothelial progenitor cell marker.  Implantation of  
these CD34+ into a MI rodent model, resulted in improved fractional shortening and 
systolic function and reduced fibrosis scar tissue [111].  When 3D aggregates of ESCs 
were cultured under hypoxia, an increased percentage of cells expressed Flk-1 and Flt-1 
earlier during EB differentiation as compared to ESCs cultured under normoxia, as well 
as increases in CD31+ (PECAM) expressing cells were observed.  Furthermore, hypoxia 
promoted development and maturation of vasculature and angiogenic outgrowth within 
EBs [24].Hypoxia pre-treatment of neuronal-differentiating ESCs resulted in a 50% 
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reduction in apoptosis and caspase-3 activation, increased expression of HIF-1α, and 
increased cell survival when transplanted into a rat ischemic brain model [132].  Low 
oxygen tension environments are more favorable than normoxic oxygen levels in 
maintaining proliferative and pluripotent stem cell populations [119, 131].  ESCs cultured 
at 20% oxygen tension displayed reduced expression of pluripotency genes Sox2, Nanog, 
and Oct4 compared to ESCs cultured at 5% oxygen. Additionally, ESCs expressed 
HIF1α, HIF2α, and HIF3α and spatial expression of HIFs within the cell was regulated 
by duration at low oxygen tension [119].  Overall, hypoxia is a key regulator of stem cell 
survival, proliferation, vascular cell differentiation and vasculogenesis. 
 
Tissue Engineering 
 In the early 1980s E. Bell et al. reconstructed skin [133] and thyroid gland [134] 
tissue from living cells and matrix materials.  Prior to this development, allogenic living 
tissue replacements were stored in tissue banks or tissue replacements were produced 
from synthetic materials.  As the field of tissue engineering has evolved focus has been 
put on developing off the shelf replacement tissues which mimic native tissue 
characteristics [135], which has led to an increased understanding of developmental 
biology and tissue formation.  Additionally, great importance has been placed on the 
tissue engineering triad which is the concept that tissue replacements must consist of 
cells, extracellular matrices, and signals[136, 137].  The need for off the shelf availability 
of tissue engineered products has rendered stem cells, which are highly proliferative, 
expandable, and easily isolated a desirable cell source option for many tissue engineered 
products.  While tissue engineering has made many strides some major challenges still 
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remain such as vascularization of tissue replacements in vitro as well as rapid 
vascularization in vivo of large and complex engineered tisues [138]. 
 
 
Modular Tissue Engineering 
 Modular tissue engineering has been employed to develop large tissues which 
better mimic the complex architecture of native tissues.  This strategy involves creating 
smaller tissues which have similar structural and biological features and then assembling 
them into a larger tissue via stacking[139, 140], directed assembly[141], or random 
aggregation[142, 143].  This approach has been utilized to vascularize tissue engineered 
constructs.  McGuiagan and colleagues demonstrated blood perfusion through sub mm 
sized tissue by assembling endothelial cell-laden collagen gel rod modules into a larger 
tissue construct.  The endothelial cells organized to form vascular networks which were 
nonthrombogenic and remained viable [144, 145].  Modular tissue engineering 
approaches represent a promising method to vascularize large tissue engineered 
constructs. 
 
Pre-Vascularization of Tissue Engineered Products 
While researchers have developed  to engineered tissues such as bone [6], heart 
[8, 10], pancreas [9], kidney [146, 147] and the spinal cord [3], in the lab setting, 
translation to clinical use has been unsuccessful due to the lack of  sufficient 
vascularization upon  implantation  in animal in vivo models.  The formation of blood 
vessels upon implantation is imperative to ensure nutrients and oxygen delivery to 
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implanted tissues as well as proper integration of the implanted tissue into surrounding 
host tissue.   In order to vascularization of implanted tissues researchers have attempted 
to pre-vascularize engineered tissues prior to implantation in hopes that these engineered 
tissues will more rapidly develop vasculature and integrate with surrounding host tissue.   
Approaches to pre-vascularize engineered tissues and promote rapid 
vascularization upon implantation include addition of vascular cells within the tissues 
[11-13]  and incorporating angiogenic factors within the tissues [8-10].  These 
approaches have not been successful for tissues with complex architecture and multiple 
layers of matrix and cells.  In addition, generating blood vessels in vitro requires the 
addition of multiple angiogenic factors at varying concentrations along with variations in 
exposure times to these factors.  Additionally, many engineered tissues are larger than 
200 μm, which is the length scale at which diffusion of molecules through tissues is 
limited. 
Various endothelial cell types, progenitor (EPCs), umbilical vein (HUVEC), and 
adult, have been utilized to pre-vascularize a multitude of tissue engineered constructs 
such as bone, cardiac, and dermal constructs.  Federovich et al. co-cultured EPCs and 
multipotent stromal cells and found that EPCs assembled into early blood vessels and 
contributed to multipotent stromal cell osteogenic differentiation [6].  When HUVECs 
were co-cultured with fibroblasts in fibrin gels for a week and then implanted into dorsal 
surface of immune-deficient mice, accelerated vascularization with the presence of 
HUVEC lined vessels containing red blood cells and significantly larger number and area 
of perfused lumens compared to non pre-vascularized constructs [11].  Furthermore, 
HUVEC prevascularization of fibroblast cell sheets promoted in vivo neovascularization 
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and network formation [13].   ECs and neural progenitor cells cultured in a PLGA and 
PEG scaffold induced significant increase in functional vessel formation when implanted 
into an injured rat spinal cord model [3].  While these studies report some success in 
vascularization by incorporating endothelial cells within engineered tissues, this approach 
is still not sufficient for development of vasculature within large tissues which will be 
used in the clinic and require using cell types which cannot be easily isolated and 
expanded.  Therefore, more vascularization approaches need to be explored which utilize 
modular tissue engineering approaches and cells which can be easily isolated, expanded 




ESC and EB Culture 
D3 and D3 pVE-cadherin GFP  murine embryonic stem cells were cultured on 
0.1% gelatin-coated tissue-culture polystyrene cultureware (Corning) in Dulbecco’s 
Modified Eagle Medium (DMEM, Mediatech) containing 15% fetal bovine serum (FBS, 
Hyclone), 1X non-essential amino acids, 2 mM L-glutamine, 100mg/mL streptomycin, 
0.25 mg/ml amphotericin, 100 U/mL penicillin, 103  U/mL leukemia inhibitory factor 
(LIF, Millipore), and 0.1 mM β-mercaptoethanol.  ESCs were fed every 2 days and 
passaged using 0.05% trypsin-EDTA (Mediatech) every 2-3 days before reaching 70-
80% confluency.  EBs were formed from single-cell suspension of 2 x 106 cells in 10 mL 
of differentiation media (DMEM with FBS and supplements except LIF) and were 
maintained in a 100 mm petri dish on a rotary orbital shaker (Lab-Line Lab Rotator, 
Barnstead) at 40 rpm (Carpenedo, 2007 #2).  Rotary orbital shakers were calibrated every 
day to ensure constant speed throughout the period of EB suspension culture.  EBs were 
re-fed every 2 days by gravity-induced sedimentation in a 15ml conical tube and 
exchanging approximately 90% of the media. 
 
Fluid Shear Pre-conditioning 
ESCs were seeded onto 28.5 cm2 glass slides pre-coated with rat tail collagen IV 
(20ug/ml solution; BD Biosciences) at a density of 20,000 cells/cm2 and cultured for 
48hrs under static conditions to allow the ESCs to form a confluent monolayer.  The 
confluent monolayer of ESCs was then subjected to either 0 dynes/cm2 (static) in a 150 
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mm petri dish or 5 dynes/cm2 (shear) fluid flow for 48 hrs using a parallel plate flow 
chamber connected to a peristaltic pump [71].  During pre-conditioning, ESCs were 
cultured in differentiation media consisting of Alpha MEM (Mediatech), 10% FBS, 100 
U/mL penicillin streptomycin, and 0.1 mM β-mercaptoethanol.  Alpha MEM is 
commonly used for ESC EC differentiation [54, 148, 149]. 
 
Quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) 
Total RNA was extracted from samples using an RNeasy Mini Kit (Qiagen).  The 
quantity and quality of RNA was determined using a Nanodrop® Spectrophotometer 
ND1000 reading at 280 nm and the ratio between the absorbance at 260 nm and 280 nm, 
respectively.  Samples with ratios between 1.7 and 2.0 were used to synthesize 
complementary DNA (cDNA) from 1 μg of total RNA using an iScript cDNA synthesis 
kit (Bio-Rad) on a thermocyler (Bio-Rad) with the following parameters: 25ºC for 5 min, 
42ºC for 30 min, 85ºC for 5 min, and store at 4ºC.  Quantitative PCR was performed 
using SYBR green technology on a MyIQ cycler (Bio-Rad); amplification was performed 
using a two-step cycling program run at the appropriate annealing temperatures for each 
primer set (40 cycles, 1min).  Primer sequences(Invitrogen) (Table 4.1) were designed 
using Beacon Designer software, validated using appropriate cell controls for target 
genes,  Flk-1 (vascular endothelial growth factor receptor 2), Flt-1 (vascular endothelial 
growth factor receptor 2), VE-cadherin (vascular endothelial cadherin), PECAM (platelet-
endothelial cell adhesion molecule), Runx1(runt related transcription factor), and Tal1 (T-
cell acute lymphocytic leukemia protein 1), AFP (alpha fetaprotein), Pax6 (Paired box 
gene 6), Nkx2.5 (cardiac specific homeobox protein), Mef2c(Myocyte-specific enhance 
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factor 2C),  GATA4 (global transcription factor 4), VEGFA (vascular endothelial growth 
factor A), and HIF1α (hypoxia inducible factor 1 alpha.  Primer sequences and annealing 
temperatures are listed in Table 1. The concentrations of the specific genes were 
calculated using a standard curve of known gene quantities and normalized to 
housekeeping gene, Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), expression 
levels. Relative fold changes (Chapters 5 and 6) were quantified relative to PC Static or 
PC Shear samples by using the Pfaffl method for quantification [150]  
 
Table 3.1: Primer Sequences and Annealing Temperatures 
Gene Forward  Reverse Temp
Flk-1 GGC GGT GGT GAC AGT ATC TGA CAG AGG CGA TGA ATG G 64.3ºC 
Flt-1 ATC GGC AGA CCA ATA CAA TC TGC TCT CTT AGT TGC TTT ACC 60.5ºC 
VE-
cadherin TGA ACC GCC AGA ATG CTA AG CCA CAA TGA GGG CAG TAA GG 57.9ºC 
PECAM CTC CTT CAC CAT CAA CAG TTA TAC ACC ATC GCA TCG 60.5ºC 
Runx1 CAC CTC TTC CTC TGT CCA C CGG AGC CGT TGA GAG TCG 64.3ºC 
Tal1 CTC ACG GCA AGC TAA GTA ACT G TGG GGC ATA TTT AGA GAG ACC TAC 60.5ºC 
AFP CAC ACC CGC TTC CCT CAT CC TTC TTC TCC GTC ACG CAC TGG 60.5ºC 
Pax6             ACGGCATGTATGATAAACTAAG GCTGAAGTCGCATCTGAG 58.0ºC 
Nkx2.5 CAA GTG CTC TCC TGC TTT CC  GGC TTT GTC CAG CTC CAC T  64.3ºC 
Mef2c CCC AAT CTT CTG CCA CTG  GGT TGC CGT ATC CAT TCC  56.1ºC 
GATA4 TGC TTT GAT GCT GGA TTT AAT TTC G CGG GTG TGC GGA ACT GTC  58.0ºC 
HIF1a GAGGTGGATATGTCTGGGTTG  AGGGAGAAAATCAAGTCGTGC  57.9ºC 
VEGFA TGCACCCACGACAGAAGG GCACACAGGACGGCTTGA 56.5ºC 










Whole-Mount Immunostaining of Embryoid Bodies 
EBs were washed in PBS (without Ca2+ and Mg2+) then fixed in 4% 
paraformaldehyde for 1 hour at 4ºC.  Following fixation, EBs were washed 3 times in 
blocking buffer containing PBS (with Ca2+ and Mg2+) 2% donkey serum and 0.1% 
Tween-20.  EBs were permeabilized with 1.5% Triton X-100 for 30 minutes and 
additionally fixed in 4% paraformaldehyde in blocking buffer for 15 minutes.  EBs were 
incubated in blocking buffer for 1-3 hours at 4ºC and incubated in the following primary 
antibodies from Santa Cruz Biotechnology: goat anti-VE-cadherin (CD144) (1:200), 
rabbit anti-PECAM (CD31) (1:200), or rabbit anti-vWF (1:200) diluted in blocking 
buffer overnight at 4ºC.  Following the overnight incubation, EBs were washed 3 times 
(15 minutes each) with blocking buffer and then incubated with a donkey anti-goat 
AlexaFluorTM  488 or  donkey anti-rabbit AlexaFluor546 TM (Invitrogen) secondary 
antibodies (1:200) and Hoescht (1:100) for 4 hours at 4ºC.  EBs were then washed 3 
times (15 minutes each) with blocking buffer and then imaged the following day using a 
Zeiss LSM 510 NLO Multiphoton confocal microscope. 
 
Flow Cytometry Analysis 
 EBs were washed in PBS (without Ca2+ and Mg2+) and  then dissociated  by 
incubating EBs with 0.05% trypsin-EDTA (Mediatech) for either 15 minutes (day 2 and 4 
EBs) or 30 minutes (day 7 EBs) at 37°C.  Dissociated cells were then quenched with ESC 
media to inactivate trypsin and then centrifuged for 5 min at 1000 rpm.  Following 
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dissociation, cells were then rinsed with cold PBS (with Ca2+ and Mg2+) containing 0.1% 
BSA, passed through a 35µm strainer and then analyzed for pVE-cadherin GFP 
expression using an Accuri C6 flow cytometer.  Undifferentiated D3s and pVE-cadherin 
GFP D3s were used as negative controls.  Approximately 27,000-33,000 events were 
recorded from 6 independent samples from each experimental group. 
 
Statistical Analysis 
Experimental treatments were investigated with a minimum of 3 independent 
replicates in independent experiments and presented as mean ± standard error of multiple 
samples.  Statistical analysis was performed using SYSTAT 12 software (Systat Software 
Inc.).  Comparisons across time points between experimental groups were made using a 
two-way analysis of variance (ANOVA) followed by post-hoc Tukey-Kramer test to 
determine significant (p<0.05) differences between different groups.  Paired t-tests were 





FLUID SHEAR STRESS PRE-CONDITIONING EFFECTS ON EMBRYONIC 
STEM CELL EMBRYOID BODY DIFFERENTIATION 
Introduction 
 Embryonic stem cells (ESCs) are an attractive cell source for numerous 
regenerative medicine and cell therapy applications because of their inherent abilities to 
differentiate into all somatic cell types[26, 27].   However, one major challenge in utility 
of these cells for such applications is efficient derivation methods to generate the desired 
homogeneous populations of differentiated cell types.  In the case of vascularization for 
replacement tissues and as a lining for vascular grafts, a source of endothelial cells (ECs) 
is imperative, due to the lack of autologous endothelial cell sources, limited expansion 
capabilities and loss of phenotype in vitro.  Lack of vascularization in engineered tissues 
leads to inability to integrate with host tissue and to cell and tissue death of engineered 
constructs.  In the case of vascular grafts ECs provides a nonthrombogenic layer to 
prevent blood clots.   Thus the critical multi-factorial role that ECs play in vascularization 
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 Current protocols to derive ECs from ESC monolyers require long culture 
periods, large concentrations of growth factors and cytokines, labor intensive cell sorting 
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and generally result in a heterogenous mixture of differentiated cell types with a low 
percentage of the cells becoming mature endothelial cells [54].  Embryoid body (EB), 3D 
aggregates of ESCs, differentiation has been employed because EBs recapitulate in vivo 
morphogenic events, such as development of mesodermal endothelial cells and 
vasculogenesis [26, 30-32, 58].  While endothelial differentiation occurs within EBs, 
there is variability from EB to EB in terms of endothelial differentiation efficiency and 
endothelial morphogenesis [30, 58].  In order to improve homogeneity and effecieency of 
differentiated cell populations in 2D ESC EC differentiation protocols, researchers have 
examined the use of mechanical forces such as fluid shear stress to derive ECs from 
ESCs.  Studies have revealed that ESCs respond to fluid shear stress by alterations in self 
renewal abilities [151], cell proliferation, and endothelial and hematopoietic gene 
expression [80, 84].  Fluid shear stress at varying magnitudes (1-15 dynes/cm2) and 
profiles (steady, pulsatile, laminar) have been employed to promote stem and progenitor 
cells to differentiate towards various cardiovascular cell types including endothelial cells, 
hematopoietic cells, and smooth muscle cells [84, 85, 89].  
Fluid shear stress has been examined because it mimics the physiological forces 
ECs experience in the body.  Fluid shear stress plays a role in EC phenotype, function, 
and homeostasis during development of vasculature and in fully developed vessels.  This 
physical force is critical for the development of the cardiovascular system, which is the 
first functioning physiological system to be established within the embryo [16, 17].  Gene 
and protein expression patterns which develop in the embryonic cardiovascular system 
are regulated by fluid shear stress, and disruption of fluid flow can lead to abnormal 
cardiogenesis and irregular  expression patterns of genes related to vasoconstriction and 
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vasodilation in the cardiac system [17, 20].  In vivo, fluid shear stress is vital for the 
proper development of the cardiac, vascular, and hematopoietic system, demonstrating 
the instructive potential of this physical force in the morphogenesis of various 
cardiovascular cell types.   
Recent studies have demonstrated that fluid shear stress has induced increased 
expression of endothelial genes in a variety of stem and progenitor cell populations.  
However, it is still unclear how this physical force modulates further endothelial 
differentiation and morphogenesis.  Therefore, the objective of this study was to examine 
the prolonged effects of fluid shear stress on ESC endothelial differentiation and 
morphogenesis by exposing ESCs to 0, 5, or 15 dyn/cm2 for 48 hrs and then further 
culturing them as embryoid bodies.  Several days after exposure to fluid shear stress, ESC 
expressed VE-cadherin and localized to the center of EBs.  Additionally, fluid shear 
stress pre-conditioning of ESCs induced EB morphogenic events, had prolonged effects 
on endothelial differentiation, and generated a population of EBs undergoing endothelial 
differentiation.  The presence of endothelial like cells within EBs formed from shear pre-
conditioned ESCs demonstrate that exposing ESCs to fluid shear stress prior to EB 









EB samples were prepared for histology after being fixed in 10% formalin for 30 
minutes at room temperature, washed 3 times with PBS, and resuspended in 200-400ul 
histogel (ThermoScientific).  Histogel-embedded EB samples were dehydrated through a 
graded series of alcohol solutions (70-100%) and xylene rinses before being infiltrated 
and embedded in paraffin.  Histological samples were sectioned at 5 μm using a 
microtome (Microm HM 355S), affixed to Superfrost Plus (VWR) glass slides, and de-
paraffinized prior to histological staining. Samples were stained with hematoxylin and 
eosin (H&E) using a Leica AutoStainer XL. 
 
Immunofluorescence of Cell Monolayers 
ESC monolayers were washed with PBS (with Ca2+ and Mg2+) 3 times prior to 
fixation in 4% paraformaldeyde for 10 minutes at room temperature.  Following fixation, 
adherent cells were washed with PBS 3x and blocked and permeabilized with PBS (with 
Ca2+ and Mg2+) containing 2% donkey serum and 0.05% Triton X-100 at room 
temperature for 45 minutes.  Monolayers were then rinsed twice with PBS and incubated 
in goat anti- Oct-4 (Santa Cruz Biotechnology) primary antibody diluted in PBS (1:200) 
containing 2% donkey serum overnight at 4ºC.  The samples were rinsed 3 times in PBS 
before incubation in a donkey anti-goat AlexaFluorTM 488 (Invitrogen) secondary 
antibody (1:200) and Hoescht (1:100) diluted in PBS (with Ca2+ and Mg2+) containing 
2% donkey serum for 1 hour at room temperature.  Monolayers were rinsed 3 times in 
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PBS (with Ca2+ and Mg2+) cover slipped using Fluoro-GelTM mounting media and imaged 
shortly thereafter using a Zeiss LSM 510 NLO multiphoton confocal microscope. 
 
Morphometric Image Analysis 
Phase images of EBs were acquired on days 2, 4, 7, and 10 during the course of 
EB differentiation with a Nikon TE 2000 inverted microscope (Nikon Inc.) equipped with 
a SpotFLEX camera (Diagnostic Instruments, Inc.).  A minimum of three fields of EBs 
per sample were analyzed using ImageJ image analysis software such that the cross-
sectional area of shear and static pre-conditioned EB samples was measured for a 
minimum of 100 EBs from independent samples (n=6).  The percentage of EBs with 
dark, centrally located foci was determined by counting the number of such EBs relative 
to the total number in the same field.  Only EBs which contained a dark or optically 
opaque, centrally located foci that constituted > 10% of the EB cross-sectional area were 
counted as an EB with a dark region. 
 
Cell Tracker Labeling-Mixing Study 
Following preconditioning ESCs were labeled with either CellTrackerTM Green 
CMFDA or CellTrackerTM Red CMTPX (Invitrogen, Molecular Probes).  Cells were 
incubated for 30 minutes in 10uM CellTrackerTM  diluted in serum free differentiation 
medium at 37ºC.  Next cells were incubated in differentiation medium for 30 minutes at 
37ºC and then rinsed with PBS.  Cells were then trypsanized and cultured as EBs in a 
100mm2 petri dishes on a rotary orbital shaker (Lab-Line Lab Rotator, Barnstead) at 
40RPM.  Embryoid bodies(EBs) were formed by combining 1E6 cells labeled red and 
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1E6 cell labeled green into a single-cell suspension of 2E6 cells in 10mL differentiation 
media(DMEM and supplements w/o LIF).  Static Green/Static Red EBs were formed 
from ESCs not preconditioned with shear labeled green and red, Shear Green/Shear Red 
EBs were comprised of shear preconditioned ESCs labeled green and red.  Mixed EBs or 
Static Green/Shear Red EBs contained ESCs not preconditioned with shear labeled green 





Fluid Shear Stress Effects on ESC Differentiation 
Following 2 days of culture on collagen IV and an additional 2 days (Fig. 4.1A) 
of culture at either 0 dyn/cm2 (Fig. 4.1B) or 5 dyn/cm2 (Fig. 4.1C), ESC populations did 
not exhibit morphological differences.  Both ESC populations  largely retained their 
undifferentiated stem cell phenotype, with the majority of static pre-conditioned ESCs 
and  shear pre-conditioned ESCs expressing Oct4 (Fig. 4. 1D&E).  Immediately after 
fluid shear pre-conditioning, endothelial and mesoderm gene, Flk-1, was approximately 
3-fold (p=0.005) higher in shear pre-conditioned ESCs compared to ESCs cultured at 0 
dyn/cm2 (Fig. 1F).   Flt-1 (VEGFR1) expression (Fig. 4.1G) was comparable in static and 
shear pre-conditioned ESCs.  ESCs pre-conditioned at 5 dyn/cm2 expressed higher levels 
of VE-cadherin (p=0.041) (Fig. 1H), PECAM (p=0.02) (Fig. 4.1I), and the hematopoietic 
transcription factor Runx1 (p=0.002) (Fig. 4.1J), as compared to ESCs not subjected to 
fluid shear stress.  Tal1 (Scl), a hematopoietic gene (Fig. 1K) was not different in ESCs 
pre-conditioned at 5 dyn/cm2 compared to ESCs pre-conditioned at 0 dyn/cm2.  There 
were no significant differences in the expression of cardiac genes GATA4, Nkx2.5, or 
Mef2c between static and shear pre-conditioned ESCs (Fig. 4.1L-N).  Static and shear 
pre-conditioned ESCs also expressed similarly low levels of endoderm gene, AFP (Fig. 
4.1O) and ectoderm gene, Pax6 (Fig. 4.1P), suggesting that fluid shear stress pre-
conditioning does not significantly affect endoderm and ectoderm differentiation.  
Although the majority of ESCs subjected to static and shear conditions largely retained 
pluripotent characteristics, the significant differences in endothelial and hematopoietic 
gene expression suggests that fluid shear stress initiated endothelial and hematopoietic 
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differentiation.  While fluid shear stress was sufficient to initiate vascular differentiation, 
it is still unclear if this initial physical modulation is sufficient for vascular differentiation 
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Embryoid Body Differentiation 
 
Following the 2 different pre-conditioning regimens (+/- shear), single-cell 
suspensions of the respective ESC populations were differentiated as EBs for up to 10 
days using rotary orbital suspension culture (Fig. 4. 2A).  Previous results from our group 
[77] [152]and others [153, 154] have indicated that continuous rotary orbital shaking 
promotes more homogeneous populations of EBs than static suspension cultures.  On the 
second day of EB culture, EBs formed from ESCs pre-conditioned under static (Fig. 4.2 
B) or shear (Fig. 4.2F) conditions appeared similar in gross morphology.  After 4 days of 
culture, morphological differences became evident, as dark foci appeared in EBs formed 
from ESCs pre-conditioned at 5 dyn/cm2 (Fig. 4.2G), while EBs formed from ESCs pre-
conditioned at 0 dyn/cm2 (Fig. 4.2C) were devoid of any such dark regions.  Differences 
in EB morphology were more apparent on day 7 (Fig. 4.2D) with the presence of 
centrally located dark regions within EBs formed from shear pre-conditioned ESCs (Fig. 
4. 2H).  After 10 days of EB differentiation the differences in EB morphology between 
static and shear pre-conditioned ESCs were not detected (Fig. 4.2E, I).  Significantly 
(p<0.001) more EBs formed from shear pre-conditioned ESCs (68.9 ± 12.4%) contained 
dark regions compared to EBs formed from statically pre-conditioned ESCs (6.1 ± 6.4%) 
(Fig. 4.2K).  However, at the same time point, the cross sectional area of (Fig. 4. 2J) EBs 
formed from ESCs pre-conditioned under static and shear were approximately 10,270.0 ± 
2,550.0 and 10,120.0 ± 2,210.0 um2, respectively.  The similarity in EB size between EB 
groups suggested that the differences in morphogenic events between EB groups were 
independent of EB size.  High magnification images of EBs containing statically pre-
conditioned ESCs revealed uniform EB morphology (Fig. 4.2L) and histological analysis 
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demonstrated no distinct cellular organization (Fig. 4. 2N).  However, EBs formed from 
shear pre-conditioned ESCs contained an optically opaque dark foci (Fig. 4.2M) centrally 
located within the EB that was similar in size to the cluster of cells observed through 
histological analysis (Fig. 4.2O).  The striking difference in morphology between EBs 
containing shear pre-conditioned and statically cultured ESCs observed several days 
following pre-conditioning suggests that initial physical modulation of ESCs induced 
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Endothelial and Hematopoietic Gene Expression 
 
To examine the subsequent effects of fluid shear stress pre-conditioning on 
cardiovascular differentiation within EBs, the temporal gene expression patterns of 
endothelial and hematopoietic differentiation markers were assessed.  Flk-1, which was 
higher in shear pre-conditioned ESCs immediately following shear pre-conditioning (i.e. 
day 0, Fig. 4.1F), remained elevated in EBs formed from shear pre-conditioned ESCs at 
days 2 (p=0.001) and 4 (p=0.009). However by day 7 and 10, Flk-1 gene levels were 
similar between EB groups (Fig. 4.3A).  While Flt-1 gene levels were initially similar 
(day 0, 2, and 4) (Fig. 4.1G, 4.3B) in both populations, by day 7, shear pre-conditioned 
EBs expressed (p=0.047) elevated Flt-1 expression compared to static pre-conditioned 
EBs (Fig. 4B).  Runx1 levels, which were higher in shear pre-conditioned ESCs prior to 
EB formation (i.e. day 0 Fig. 4.1J), were also higher in shear pre-conditioned EBs 
compared to static pre-conditioned EBs at day 4 (p=0.03) and day 7 (p=0.001) and 
similar at day 10 (Fig. 4.3C).  VE-cadherin expression levels were greater in shear pre-
conditioned ESCs (day 0, Fig. 4. 1H) and higher at day 7 in EBs formed from shear pre-
conditioned (p=0.012) ESCs when compared to EBs formed from statically pre-
conditioned ESCs (Fig. 4.3D).  While PECAM expression levels were initially higher in 
shear pre-conditioned ESCs (i.e. day 0, Fig. 4.1I), on day 2, PECAM expression levels 
were (p=0.014) lower in shear pre-conditioned EBs.  However, PECAM expression was 
higher on day 7 (p=0.01) and day 10 (p=0.02) (Fig. 4.3E) in shear pre-conditioned EBs 
when compared to static pre-conditioned EBs.  No differences in Tal1 gene expression 
were detected between static and shear pre-conditioned ESCs (i.e. day 0, Fig. 4.1K) or 
pre-conditioned EB groups until day 10 when static pre-conditioned EBs expressed 
37 
(p=0.001) more Tal1 than shear pre-conditioned EBs (Fig. 4.3F).  Following 7 days of 
EB differentiation, the time point at which distinct differences in EB morphology 
between shear and static pre-conditioned EBs were observed, 3 of the 4 endothelial genes 
examined, Flt-1, VE-cadherin, and PECAM were higher in shear pre-conditioned EBs.  
The differences in endothelial marker gene expression observed in EBs formed from 
statically cultured ESCs and shear pre-conditioned ESCs indicates fluid shear pre-
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Embryoid Body Endothelial Protein Expression 
To assess persistent effects of fluid shear stress pre-conditioning on ESC 
endothelial and hematopoietic differentiation within EBs endothelial and hematopoietic 
protein expression was analyzed.  The presence of endothelial cells within EBs was 
analyzed by immunofluorescence staining of VE-cadherin, vWF, and PECAM.  EBs 
formed from ESCs cultured under static conditions (0 dyn/cm2) did not appear to contain 
VE-cadherin positive cells at any of the time points examined (days 2, 4, 7, 10; Fig. 
4.4A-D).  However EBs containing shear pre-conditioned ESCs stained positively for 
VE-cadherin at all time points examined and the VE-cadherin positive cells remained 
centrally clustered within the EBs throughout differentiation (Fig. 4. 4E-H).  Co-
localization of the dark regions and VE-cadherin+ cell clusters was analyzed in day 7 
EBs formed from static (Fig. 4.4I-K) and shear pre-conditioned groups. The dark regions 
observed by phase contrast microscopy in day 7 EBs containing shear pre-conditioned 
ESCs, overlapped with similar size VE-cadherin positive cell clusters (Fig. 4.4O-Q).  Day 
7 EBs formed from statically cultured ESCs were not positive for vWF (Fig. 4.4L-N).  
However, the VE-cadherin+ cell clusters within day 7 EBs formed from shear pre-
conditioned ESCs exhibited co-localized staining for vWF expression, a more mature 
endothelial marker (Fig. 4.4R-T).  While vWF was detected at day 7, vWF was not 
detected at days 2 or 4, suggesting that the VE-cadherin positive ESCs were 
differentiating into mature endothelial cells within the EB.  Day 7 EBs formed from 
ESCs not pre-conditioned with shear lacked vWF expression (Fig.6. 4L-M).  PECAM, 
CD45 CD34, and CD41 expression was not detected in EBs formed from shear or static 
pre-conditioned ESCs. These results reveal that fluid shear stress pre-conditioning 
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promoted VE-cadherin protein expression in ESCs which led to specific VE-cadherin 
positive cell clustering at the center of EBs.  Additionally, the EB microenvironment 
promoted further differentiation of endothelial like cells, as VE-Cadherin+ cells 
developed expression of a more mature endothelial marker protein vWF.  Moreover, the 
expression of endothelial proteins VE-cadherin and vWF along with significantly higher 
expression of endothelial genes VE-cadherin, PECAM, and Flt-1 on day 7 of EB 
differentiation reveals that fluid shear stress pre-conditioning promoted EB endothelial 
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Mixed Embryoid Bodies 
To investigate cellular organization and segregation of different cell phenotypes 
within EBs, static and shear pre-conditioned ESCs were labeled with either 
CellTrackerTM Red or Green after pre-conditioning and prior to EB formation.  Three 
groups of EBs were formed; 1) EBs containing green and red static pre-conditioned 
ESCs, 2) EBs containing green and red shear pre-conditioned ESCs, and 3) EBs 
containing green static pre-conditioned ESCs and red shear pre-conditioned ESCs.  EBs 
formed from static pre-conditioned ESCs labeled green and red did not exhibit any 
distinct cellular organization with red and green cells dispersed randomly throughout the 
EB at day 2 and 7 (Fig. 4.5A, D).  However, day 2 and 7 EBs containing shear pre-
conditioned ESCs labeled green and red contained clusters of cells centrally located 
within the EB composed of red and green cells (Fig. 4.5B, E).  The cellular organization, 
location and size of labeled shear pre-conditioned ESCs within EBs was similar to that of 
the VE-cadherin+ cell clusters and dark regions previously observed.  When green 
labeled static pre-conditioned ESCs and red labeled shear pre-conditioned ESCs were 
mixed to form EBs, clusters of cells centrally located within the EBs were observed (Fig. 
4.5C, F).   But, at day 2 these clusters only contained shear pre-conditioned ESCs labeled 
red, with static pre-conditioned ESCs labeled green located on the periphery of the EB.  
The same cellular organization persisted after 7 days of EB differentiation. These 
observations illustrate how different cell phenotypes, static pre-conditioned ESCs and 
shear pre-conditioned ESCs, spatially organized and segregated within EBs and 
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Fluid Shear Pre-conditioning of pVE-cadherin GFP ESCs 
 In order to track VE-cadherin expression in ESCs after fluid shear stress pre-
conditioning and during EB differentiation, pVE-cadherin GFP ESCs (VE-GFP ESCs) 
were cultured with or without shear for 48 hrs and then cultured as EBs for 7 days.  Using 
VE-GFP ESCs allowed for real time visualization of VE-cadherin expression after shear 
pre-conditioning and during EB differentiation   Moreover, GFP as a readout for VE-
cadherin expression allowed for direct detection of VE-cadherin positive cells rather than 
indirect detection of VE-cadherin+ cells (immunofluorescence, i.e. primary and 
secondary antibody coupling). Initial GFP expression was assessed in undifferentiated 
VE-GFP ESCs using fluorescence microscopy and flow cytometry.  Undifferentiated VE-
GFP ESCs displayed no detectable levels of GFP expression (Fig. 4.6A).  Following the 
two pre-conditioning regimens, GFP+ ESCs were not observed in monolayers of ESCs 
pre-conditioned statically (Fig. 4.6B); however, GFP+ ESCs were visible through 
fluorescence microscopy in shear pre-conditioned populations (Fig. 4.6C).  Flow 
cytometry analysis of GFP expression revealed 2.0% ±  0.1%, 21.6% ±3.1%, and 23.4% 
± 4.3% of undifferentiated, statically pre-conditioned, and shear pre-conditioned VE-GFP 
ESCs were GFP (VE-cadherin) positive, respectively (Fig. 4.6D-F).  While no 
differences in the percentage of GFP+ cells between shear and statically pre-conditioned 
groups was detected, the GFP mean fluorescence intensity was significantly higher 
(p=0.015) in shear pre-conditioned VE-GFP ESCs (1146 ± 119 fluorescence intensity) 
compared to statically pre-conditioned VE-GFP ESCs (964 ± 82 fluorescence intensity) 
(Fig. 4.6G).  Furthermore, there was a larger shift in GFP mean peak fluorescence 
intensity between undifferentiated and shear pre-conditioned VE-GFP ESCs compared to 
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the shift in GFP mean peak fluorescence intensity between undifferentiated and statically 
pre-conditioned VE-GFP ESCs (Fig. 4.6H-I).  Day 7 EBs formed from statically pre-
conditioned VE-GFP ESCs were devoid of dark regions and GFP+ cell clusters (Fig. 
4.7A,B), which paralleled day 7 EBs formed from statically pre-conditioned ESCs (Fig. 
4.7F).  Throughout EB differentiation, GFP+ cells were not observed in statically pre-
conditioned VE-GFP EBs (Fig. 4.7C-E).  However, EBs formed from shear pre-
conditioned VE-GFP ESCs exhibited dark regions at day 7 (Fig. 4.7F) which co-localized 
with the dark regions at the center of the EBs (Fig. 4.7G), similar to those observed 
previously with non-transfected shear pre-conditioned ESCs (Fig. 4.7G).  Furthermore, 
GFP+ cell clusters were observed in EBs formed from shear pre-conditioned VE-GFP 
ESCs (Fig. 4.7H-J) at all time points examined. The dark regions and GFP+ cell clusters 
observed in EBs formed from shear pre-conditioned VE-GFP ESCs confirmed the 
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Fluid Shear Stress Magnitude Effects on ESCs  
Following 48 hours of fluid shear stress stimulation, ESC morphology and 
differentiation were examined.  ESCs cultured under static, 5 dyn/cm2, and 15 dyne/cm2 
(Fig. 4.8 A-C) displayed no distinct differences in morphology.  Flk-1, a mesoderm gene 
and VEGF receptor gene expressed by endothelial cells was higher in ESCs exposed to 5 
and 15 dyn/cm2 compared to ESCs cultured statically (Fig. 4.8D).  However, fluid shear 
stress decreased Pax6, an ectoderm gene (Fig. 4.8E).  Fluid shear stress had on AFP 
expression as all ESC groups expressed similarly low levels of AFP, a marker for 
endoderm differentiation (Fig. 4.8F). Vascular endothelial cadherin, a cadherin 
exclusively expressed on endothelial cells, was increased in shear pre-conditioned ESCs 
(p<0.05) (Fig. 4.8G).  However, Flt-1, VEGF receptor 1, was only higher (p<0.05) in 
ESCs pre-conditioned at 5 dyn/cm2 compared to ESCs cultured statically (Fig. 4.8H).  
PECAM expression was not different between statically cultured or shear pre-conditioned 
ESCs.   Overall the data suggested that exposing ESCs to fluid shear initiates mesodermal 
endothelial differentiation.  In general, there were few differences in gene expression 
between the two shear regimens suggesting that the fluid shear stress physical 
stimulation, irrespective of fluid shear stress magnitude promotes an endothelial 
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Following the 3 different pre-conditioning regimens (static, 5 dyn/cm2, 15 
dyn/cm2), single-cell suspensions of the respective ESC populations were differentiated 
as EBs for up to 10 days using rotary orbital suspension culture (Fig. 4.9A).  On the 
second day of EB culture, ESCs pre-conditioned at 0, 5, and 15 dyn/cm2 yielded 
significantly different amounts of EBs (0 dyn/cm2 - 2,716 ± 196, 5 dyn/cm2-4, 6377 ± 
510,  15 dyn/cm2 7,167 ± 440 EBs per plate) (Fig. 4.9A).  While the EB cross sectional 
area for 0, 5, and 15 dyn/cm2 was 8,44.8 ± 265.5, 6,643.3 ± 156.8, 11,686.5 ± 327.5 um2, 
respectively (Fig. 4.9B-E).  The differences in EB yield and cross sectional area after 2 
days of EB culture between EB groups suggests that fluid shear stress affects subsequent 
aggregation kinetics of ESCs.  After 4 days of culture, morphological differences became 
evident, as dark foci appeared in EBs formed from ESCs pre-conditioned at 5 and 15 
dyn/cm2 (Fig. 4.9G,H), while EBs formed from ESCs pre-conditioned at 0 dyn/cm2 (Fig. 
4.9F) were devoid of any such dark regions (8.3 ± 2.4%).  Differences in EB morphology 
became more apparent on day 7 (Fig. 4.9I) with the presence of dark regions within EBs 
formed from shear pre-conditioned ESCs (Fig. 4.9J,K). While both EB groups formed 
from shear pre-conditioned ESCs developed dark regions, the spatial patterning of the 
dark regions between groups was distinctly different.  EBs formed from ESCs pre-
conditioned at 5 dyn/cm2  (67.7 ± 2.4%)  developed dark regions which localized to the 
center of the EB while EBs formed from ESCs pre-conditioned at 15 dyn/cm2 (66.6 ± 
2.4%) developed dark regions that varied in shape and location within EBs, yielding a 
more morphologically heterogenous EB population (Fig. 4.9 J,K).  By day 10, all EB 
groups looked distinctly different from one another (Fig. 4.9L-N), with dark regions only 




















































































Figure 4.9.  Embryoid Body Morphology.  After 2 days of EB differentiation statically 
cultured ESCs formed fewer EBs compared to ESCs exposed to shear (A) (n=3-6,*= 
p<0.05).  Day 2 embryoid body size was largest in ESCs pre-conditioned at 15 dyn/cm2 
(B) (n=4 (total of 110-118 EBs), *=p<0.05).  Phase images of EBs formed from ESCs 
cultured at 0 dyn/cm2 (C, F, I, L), 5dyn/cm2 (D, G, J, M), and 15 dyn/cm2 (E, H, K, N) 
exhibited distinct differences in EB morphology at day 7 and 10 of EB culture with the 
presence of dark regions in 5 and 15 dyn/cm2 groups(scale bar=400μm, inset scale 
bar=100μm).  Following 7 days of EB culture, EBs formed from statically pre-
conditioned ESCs did not develop dark regions while EBs formed from shear pre-
conditioned ESCs developed significantly more dark regions (D) (n=9 fields from 3 





Endothelial morphogenesis and differentiation were assessed at day 7 by 
examining expression of endothelial adhesion molecules vascular endothelial cadherin 
(VE-cadherin) and platelet endothelial cell adhesion molecule (PECAM).  VE-cadherin 
was not detected in the static EBs (Fig. 4.10E); however VE-cadherin positive cell 
clusters were detected in EBs formed from ESCs cultured at 5 (Fig. 4.10F) and 15 
dyn/cm2(Fig. 4.10G).  More interestingly, the VE-cadherin+ cell clusters observed at the 
center of the EBs co-localized with the dark regions observed in the phase images.  VE-
cadherin positive cell clusters were only observed at the center of the EB in a circular 
pattern.  PECAM expression was not detected in any of the EBs.  The correlation 
between EB morphology and VE-cadherin+ cellular organization within shear pre-
conditioned EBs at day 7 indicated that these EBs underwent endothelial morphogenesis 
and that fluid shear stress pre-conditioning of ESCs had prolonged effects on endothelial 




















































































Embryoid Body Endothelial Gene Expression 
 Immediately after exposure to fluid shear stress, ESCs expressed significantly 
higher levels of endothelial genes. Therefore in order to examine if exposure to fluid 
shear stress had extended effects on endothelial differentiation, genes Flk-1, Flt-1, VE-
cadherin, and PECAM were analyzed during EB differentiation of shear pre-conditioned 
ESCs.  Flk-1 levels in EBs containing ESCs pre-conditioned at 5 dyn/cm2 was highest at 
day 2 compared to the other time points examined and then progressively decreased from 
day 2 to day 10 (Fig. 4.11 A).  ESCs cultured statically and at 15 dyn/cm2 did not display 
any significant changes in Flk-1 expression during EB culture.  EBs formed from ESCs 
cultured under static conditions expressed higher levels of Flt-1 on day 2 compared to 
day 7.  While EBs formed from ESCs exposed to 5 dyn/cm2 shear stress expressed 
decreased levels of Flt-1 on day 7 compared to all other time points examined (Fig. 4.11-
B).  VE-cadherin expression peaked at day 4 in EBs groups formed from statically 
cultured ESCs and ESCs exposed to 5 dyn/cm2 shear stress (Fig. 4.11C).  PECAM gene 
expression remained relatively low in EB groups and was not altered between EB groups 
or across time points (Fig. 4.11D).  Lack of PECAM gene expression changes correlated 
with low levels of PECAM protein expression observed in day 7 EB groups.  The 
changes and differences in endothelial gene expression profile of EBs formed from shear 
pre-conditioned ESCs indicated that fluid shear stress has prolonged effects on EB 
endothelial differentiation profile and modulates EB temporal endothelial marker gene 
expression.   However, in general no significant differences were detected between EB 
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In this study, the extended effects of fluid shear stress pre-conditioning on ESCs 
endothelial differentiation and morphogenesis within EBs were assessed.  Immediately 
following fluid shear stress exposure, ESCs expressed elevated levels of endothelial 
genes while still retaining pluripotent characteristics.  Centrally organized clusters of VE-
cadherin+ cells were observed as early as 2 days following initial formation of EBs from 
shear pre-conditioned ESCs.  The central clusters of cells, observed in EBs formed from 
shear pre-conditioned ESCs, which were clearly distinguishable by phase contrast 
microscopy alone at day 7, persisted for up to 10 days of differentiation in suspension 
culture.  Moreover, EBs formed from shear pre-conditioned ESCs expressed significantly 
more endothelial genes on day 7 than EBs formed from static pre-conditioned ESCs.  
GFP+ cell cluster formation in EBs formed from shear pre-conditioned VE-GFP ESCs 
verifies the results observed in EBs formed from shear pre-conditioned ESCs. The results 
revealed that fluid shear stress increased expression of endothelial markers Flk-1, 
PECAM, and VE-cadherin, which leads to increased endothelial differentiation, as well 
as endothelial cell patterning, and morphogenesis of ESCs within EBs.  More specifically 
this study demonstrates fluid shear stress stimulation of ESCs during early differentiation 
has persistent effects on ESC EC differentiation and morphogenesis. 
Recent studies have examined accute effects of fluid shear stress on ESC 
differentiation. However, ESC differentiation profile and morphogenesis within EBs days 
after fluid shear exposure have not been examined [81, 85, 148].  Previous studies 
examining the effects of fluid shear stress on ESC monolayers have reported increases in 
endothelial genes and proteins, such as Flk-1, Flt-1, PECAM, and VE-cadherin, and 
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ability to form tubular structures and uptake acetylated LDL [80, 84, 148].  In such 
studies, varying manners and magnitudes of fluid shear stress have been examined, 
including pulsatile and laminar at magnitudes ranging from 0.98 to 10 dynes/cm2 [84, 
85]. While initial studies were performed examining 5 and 15 dyn/cm2, gene expression, 
protein expression and EB morphogenesis results were similar.  However for the studies 
reported herein, 5 dyn/cm2 was investigated further because this magnitude is more 
representative of the physiological shear stress embryonic stem cells experience in the 
embryo since the wall shear stress in the dorsal aorta at day 10.5 of development in the 
mouse embryo is 5 dyn/cm2 [89]. An increase in the expression of Runx1 in shear-
preconditioned ESCs parallels the results of a recent study in which mouse ESC Flk-1+ 
cells isolated from EBs cultured for 3.25 days and sheared at 5 dyn/cm2 for 30 hours 
demonstrated an increased expression of Runx1 and CD41 [89].  In addition, ESC-
derived endothelial cells, vascular progenitor cells, and hematopoietic progenitor cells 
have been reported to exhibit changes in morphology and increased expression of 
endothelial, vascular, and hematopoietic genes in response to fluid shear stress exposure 
[85-87, 89, 155].  In contrast to previous studies which focused primarily on examining 
the phenotype effects of fluid shear stress on stem cells  immediately following the 
application of shear stress, this study examined the temporal response of fluid shear pre-
conditioned ESCs undergoing differentiation as EBs and the downstream effects of fluid 
shear stress on ESC differentiation. 
 Endothelial and hematopoietic cells originate from mesoderm via a common 
precursor, the hemangioblast [59, 60].  The hemangioblast is defined by its expression of 
Flk-1, SCL/Tal-1, CD34, and CD133, [61, 62, 156].  During early embryogenesis, 
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aggregates of hemangioblasts in the extraembryonic yolk sac(primitive hematopoiesis) 
and aorta-gonad-mesonphros (definitive hematopoiesis) mature and form blood islands, 
which consist of an inner core of blood cells and an outer layer of endothelial cells [63, 
157].  The organization of hematopoietic and endothelial cells into blood islands initiates 
the onset of vascular development and expansion, whereby blood island cells migrate, 
divide, and create connections to form the yolk sac vasculature [58].  The striking 
similarities in morphology between the dark regions observed in EBs formed from shear 
pre-conditioned ESCs and blood islands, which appear dark in contrast to other parts of 
the developing embryo, develop at the center of the embryo and are comprised of 
endothelial cells, suggests that EBs formed from shear pre-conditioned ESCs may be 
recapitulating yolk sac hematopoiesis [30, 156, 158].  In the developing embryo blood 
islands develop in the center of the embryo, are optically opaque and darker in contrast 
compared to other regions of the embryo [157, 159].  Moreover, the co-expression of  
VE-cadherin and vWF, a prothrombotic glycoprotein synthesized and secreted by 
vascular endothelial cells for platelet adhesion to sites of vascular damage [160], 
indicates that the cluster of cells are becoming mature endothelial cells.  The endothelial 
maturation of fluid shear stress pre-conditioned ESCs at the center of EBs suggests that 
the EB microenvironment supports ESC endothelial differentiation and subsequent 
maturation. 
The organization of VE-cadherin+ cells within EBs formed from shear pre-
conditioned ESCs illustrates cadherin mediated selective cell adhesion and indicates that 
these cells are differentiating into endothelial cells.  Cadherins play an important role in 
selective cell adhesion, tissue organization, segregation and morphogenesis [161, 162].  
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In vitro, cadherins played a role in the reorganization of single cells dissociated from 
chick embryonic liver, kidney and skin when implanted back into the chick embryo, to 
form liver, kidney, and skin tissue having a similar architecture and morphology as found 
in the naturally developing embryo [163].  VE-cadherin, a cadherin specifically 
expressed at the intercellular junctions of endothelial cells [164] is essential for vascular 
morphogenesis [165, 166].  Vascular formation during embryogenesis is imperative for 
the development of the cardiovascular system, which supplies oxygen and nutrients to all 
developing tissues.  Therefore, lack of VE-cadherin would lead to impaired tissue 
morphogenesis of developing organs, vasculogenesis and angiogenesis within the embryo 
[165].  The presence of VE-cadherin+ cells at the core of EBs is analogous to previous in 
vitro studies in which VE-cadherin+ cell clusters were observed in day 6 EBs cultured 
with an angiogenic growth factor mixture [55], suggesting that fluid shear stress pre-
conditioning accelerated the kinetics of vascular differentiation of ESCs similar to 
angiogenic factors.   
The maturation of VE-cadherin+ ESCs following fluid shear pre-conditioning 
during EB culture suggests that the EB microenvironment promotes endothelial 
differentiation.  One such microenvironment property which may have played a role in 
endothelial maturation and differentiation is hypoxia.  EBs which exceed 200um in 
diameter generally develop necrotic cores due to lack of oxygen and nutrient 
transport[167].  By day 7 EBs formed from shear pre-conditioned ESCs had diameters 
which suggest oxygen gradients were present within the EB.  Hypoxia has been reported 
to promote ESC vascular differentiation, endothelial expansion, and angiogenesis within 
EBs [24, 111].  Additionally, hypoxia mediates temporal expression of VEGF receptors, 
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Flk-1 and Flt-1 [24].  During embryogenesis, hematopoiesis and angiogenesis occur as 
diffusion of oxygen is inhibited due to embryo growth, causing an oxygen gradient, 
throughout the embryo, [18] which regulates, Flk-1, Flt-1, and VEGF, genes required for 
differentiation and organization of the cardiovascular system [25].  
The differences in EB yield and size between statically cultured and shear pre-
conditioned ESCs indicated differences in aggregation kinetics during EB formation.  
Undifferentiated ESC aggregation during EB formation is mediated by E-cadherin 
binding [75], while ESCs which lack E-cadherin fail to aggregate [153].  Several studies 
have demonstrated that when cells expression different cadherin subtypes are cultured in 
suspension form aggregates with cells expressing similar cadherins [168, 169].  
Additionally, differences in EB cross sectional area may have been attributed to increased 
proliferation of fluid shear pre-conditioned ESCs [81, 85].   
The findings of this study reveal that fluid shear stress has subsequent effects on 
ESC endothelial differentiation and primitive vascularization within EBs.  The results 
illustrate that pre-conditioning ESCs with fluid shear stress prior to EB formation 
enhanced endothelial differentiation within EBs and yielded approximately 70% of EBs 
containing cells undergoing endothelial differentiation.   In addition, fluid shear stress 
induced ESCs to express an endothelial specific cadherin which appeared to promote 
subsequent specific cell adhesion and organization, and vascular morphogenesis within 
EBs.  Furthermore, the morphogenic events and gene expression patterns observed in 
EBs formed from shear pre-conditioned ESCs 7 days following physical stimulation 
provides evidence that physical modulation of ESCs during early differentiation has 




The findings of this study revealed that fluid shear stress has subsequent effects 
on ESC endothelial differentiation and localization and patterning of VE-cadherin 
positive cells in EBs.  Applying different magnitudes of fluid shear to ESCs prior to EB 
formation elicited differences in EB morphology but only subtle differences in 
endothelial marker gene expression profile.  However, major differences were observed 
between shear pre-condiitoned ESCs and ESCs cultured statically.  ESCs pre-conditioned 
with shear underwent distinctly different morphogenic events within EBs compared to 
ESCs cultured statically.  Additionally, pre-conditioning ESCs prior to EB formation led 
to a unique endothelial gene expression profile when compared to statically culturing 
ESCs.  Furthermore, dark centrally located regions, only observed in EBs formed shear 
pre-conditioned EBs, correlated with the organization of endothelial-like cells at the 
center of the EB.  Altogether, the results demonstrate that exposing ESCs to shear 






VEGF EFFECTS ON ENDOTHELIAL DIFFERENTIATION OF 
FLUID SHEAR STRESS PRE-CONDITIONED EMBRYONIC STEM 
CELLS 
Introduction 
Pluripotent embryonic stem cells (ESCs) represent an attractive cell source for 
regenerative medicine and tissue engineering applications due to their inherent ability to 
differentiate into numerous cell types needed for therapies to replace a variety of 
damaged tissues.  For cardiovascular applications, endothelial cells (ECs) are needed to 
line the vascular grafts and to provide vascularization in tissue engineered substitutes.  
Acquiring, isolating, and expanding the quantities of endothelial and endothelial 
progenitor cells required for tissue engineering applications is difficult due to loss of 
phenotype in vitro and decrease in quantities found in vivo [170, 171].  Challenges in 
isolation and expansion of autologous EC sources demonstrate the need for new potential 
cell sources for ECs.   
Established protocols to derive endothelial cells from embryonic stem cell (ESC) 
monolayers require extensive culture periods and labor intensive cell sorting methods.  
Additionally, these methods use large quantities of VEGF and extracellular matrix, only 
yielding heterogeneous populations with few cells expressing markers for endothelial 
differentiation such as, Flk-1 and VE-cadherin [54, 149]  In order to overcome the 
challenges of using chemical cues to derive ECs from ESCs, physical cues have been 
investigated as an alternative method.  Fluid shear stress, which is experienced by 
64 
endothelial cells in vivo, has been utilized to promote endothelial differentiation of a 
multitude of stem and progenitor cell populations [81, 88, 148, 172].   
EBs can give rise to cells of the 3 germ layers including, endothelial cells [32, 58, 
173].  However, without directed differentiation strategies such as growth factor 
stimulation, endothelial differentiation within EBs is heterogeneous and inefficient [58, 
173].  In order to more efficiently direct endothelial differentiation within EBs, 
researchers have used growth factors such as VEGF [45, 55].  Soluble delivery of growth 
factors has led to inefficient EB differentiation because soluble delivery of molecules 
generally only affects the cells at the periphery of the EB due to diffusion barriers at the 
exterior of the EB [174, 175].  The EB outer layer of tight cell-cell contacts is a great 
limitation in using growth factors to direct and control EB differentiation.  To overcome 
diffusion limits at the exterior of EBs, the McDevitt laboratory has developed a method 
to deliver growth factors at the interior of the EB through use of microparticles or 
micropsheres which have the ability to bind and release morphogens [174].  
Microparticles can be made of adhesive extracellular matrix with which cells can 
potentially bind and interact.  Therefore, during EB formation mircoparticles can be 
incorporated within the EB structure by allowing ESCs and microparticles to aggregate 
together.  Once the microparticles are within the EB they can locally release growth 
factors and potentially affect ESC differentiation within the EB. 
Previous studies in chapters 3 and 4 have revealed that pre-conditioning ESCS 
prior to EB differentiation elicits clustering of endothelial like cells (VE-cadherin+) at the 
center of EBs.  Thus, this study aimed to further direct endothelial differentiation in EBs 
by pre-conditioning ESCs with fluid shear stress prior to EB formation and then treating 
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these EBs with VEGF.  Two methods of VEGF delivery were examined 1) soluble and 2)   
via microparticles.  VEGF was delivered via microparticles to allow for VEGF release 
within the interior of the EB in contrast to soluble deliver which relies on free diffusion 
of factors from the outside of the EB into the interior of the EB.  The effects of VEGF 
stimulation on directing EB endothelial differentiation, endothelial morphogenesis, and 
cell patterning within EBs were analyzed and compared in EBs formed from statically 




ESC and EB Culture 
D3 and D3 pVE-cadherin GFP  ESCs as previously described in Chapter 3.  EBs 
treated with soluble VEGF were fed with differentiation media supplemented with 
50ng/ml VEGF (R&D and maintained on a rotary orbital shaker (Chapter 3).  EBs which 
contained gelatin microparticles (MPs) were formed by placing ≈2 x 106 cells and            
≈ 666,000 gelatin MPs (1 MP:3 cells) in 10mL of differentiation media on a rotary orbital 
shaker.   
 
Gelatin Microparticle Fabrication and VEGF Loading 
Gelatin microparticles (MPs) were fabricated using an adaptation of a previously 
published protocol [176].  2mL of a 10% w/v solution of gelatin B (Sigma Aldrich) in 
deionized water as heated to 55C and then added drop-wise to 60mL of corn oil and 
homogenized for 5min at 5000RPM in order to create a water-in-oil emulsion.  Following 
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homogenization the solution was cooled for 10 min at 4C.  The MPs were then retrieved 
through centrifugation at 200xg and washed in 25mL acetone 3 times.  Next the MPs 
were crosslinked at room temperature with 5mM gluteraldehyde, 0.1% w/v Tween 20 
solution in deionized water under agitation.  Following 15 hours of crosslinking, the MPs 
were centriguged and treated with 25mL of 25mM glycine in deionized water to block 
residual aldehyde groups.  MPs were washed 3 times in 25mL deionized water.  Prior to 
use for EB incorporation, gelatin MPs were loaded with VEGF by adding 125ng of 
VEGF to 1mg (≈2.5 E 6 MPs) of MPs briefly centrifuged (15-30s) and then incubated at 
4C for 4-6 hours.  Unloaded gelatin MPs (-VEGF MPs) and VEGF loaded gelatin MPs 
(+VEGF MPs) were used for experiments. 
 
Immunostaining of Cryosectioned EBs  
EB samples were prepared for cryofixation after being fixed in 10% formalin for 
30 minutes at room temperature, washed 3 times with PBS, and resuspended in 200-
400ul Histogel.  Histogel-embedded EB samples were soaked in 30% sucrose at 4°C 
overnight followed by infiltration with sucrose and OCT solutions under vacuum at -
20inHg pressure.  Optimal sucrose and OCT infiltration were accomplished by serially 
decreasing the volume of sucrose and increasing the volume of OCT through use of the 
following 20% sucrose:OCT ratio by volume solutions; 4:1, 2:1, 1:2, and 0:1.  Samples 
were then embedded in OCT in a cryomold in dry ice and 95% ethanol to allow for quick 
freezing to prevent ice crystal formation.  OCT samples were then sectioned at 10 μm 
using a cryostat (LEICA Cryostat HM 355S), affixed to Superfrost Plus (VWR) glass 
slides. Cryosectioned samples were then fixed using acetone for 10 min at -20°C, rinsed 
67 
3 times with PBS for 5 minutes, and then blocked using 2% donkey serum in PBS for 45 
min at room temperature.  Next samples were rinsed twice in PBS for 5 min and then 
incubated with primary antibody (1:200) diluted in 2% donkey serum in PBS at 4°C 
overnight.   Following primary incubation sections were rinsed 3 times in PBS for 5 
minutes and then incubated with secondary antibody (1:500) and Hoechst (1:100) diluted 
in 2% donkey serum in PBS for 1 hr at room temperature.  Samples were then rinsed in 
PBS 3 times, coverslipped using Flouregel Mounting media, and then imaged the 


















Embryoid Body Morphology 
 Following pre-conditioning (+/- shear), ESCs were further differentiated as EBs 
and treated either with (+VEGF) or without (-VEGF) soluble VEGF, with microparticles 
loaded with VEGF (+VEGF MPs), or unloaded microparticles (-VEGF MPs).  During 
EB differentiation of soluble and microparticle VEGF treatment elicited vastly different 
EB morphologies between PC Static and PC Shear EB groups.  At day 2, EBs which did 
not contain microparticles (Fig. 5.1 A, B, E, F) and were more homogeneous in shape and 
size in comparison to EBs which contained microparticles (Fig. 5.1 C,D, G, H).  
Following 4 days of EB differentiation, PC Shear –VEGF EBs (Fig. 5.1 I) developed 
large dark regions which were not observed in PC Shear +VEGF EBs (Fig. 5.1 N).  Day 
4 PC Static +VEGF MPs EB (Fig. 5.1K) appeared larger in size compared to all other EB 
groups.  By day 4 EBs which did contain microparticles no longer exhibited uniform 
shape and size (Fig. 5.1, I, J, M, N).  On day 7, PC Static –VEGF (Fig. 5.1Q) and PC 
Static +VEGF (Fig. 5.1R) EBs displayed a similar morphology with very few EBs 
developing dark regions.  As observed in previous studies, dark regions within day 7 PC 
Shear EBs were indicative of VE-cadherin positive cell clustering (Chapter 3).   On the 
other hand, day 7 PC Static EBs + VEGF MPs (Fig. 5.1S) and –VEGF MPs (Fig. 5.1T) 
both developed variable-sized dark regions within the EB populations.  In contrast to the 
PC static –VEGF EBs, PC Shear –VEGF EBs (Fig.. 4.1U) developed dark foci at the 
center of the EBs.  However, after 7 days of soluble VEGF treatment of PC Shear EBs 
(Fig. 5.1 F), dark regions were not observed.  PC Shear +VEGF MPs (Fig. 5.1G) and PC 
Shear –VEGF MPs (Fig. 5.1H) developed similar morphology to PC Static EBs treated 
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with MPs, as they contained optically opaque regions of varying sizes throughout the EB 
samples.  Altogether, the distinct differences in EB morphologies between PC Static and 
PC Shear EBs induced by VEGF treatment (+/- VEGF) and VEGF treatment method 
(soluble vs. released from MPs) demonstrated that VEGF has an effect on EB 
morphology and morphogenesis.  Moreover, soluble VEGF treatment elicited a different 





Figure 5.1:   Embryoid Body Morphology.  Following 2 days of EB culture EBs not 
containing microparticles (A, B, E, F) were more uniform than EBs which contained 
microparticles (C, D, G, H).  At day 4 soluble VEGF treatment did not elicit different EB 
morphology in PC Static EBs (I, J).  However, on day 4 PC Shear –VEGF EBs (M) 
contained dark regions which were not observed in PC Shear +VEGF EBs (N). By day 4 
PC Static +VEGF MP EBs (K) appeared larger in sized compared to all other day 4 EB 
groups.   Day 4 PC Static –VEGF MPs (L), PC Shear + VEGF MPs (O) and PC Shear –
VEGF MPs appeared similar morphologically (P).  At day 7, PC Static –VEGF EBs (Q) 
look similar in morphology to PC Static +VEGF EBs (R).  However, PC Static +VEGF 
MPs (S) and PC Static –VEGF MPs (T) develop a distinctly different morphology with 
noticeable dark foci of varying sizes throughout the EB populations.  PC Shear –VEGF 
EBs developed dark regions at the centroid (U).   While dark regions were not observed 
in PC Shear +VEGF EBs (V), PC Shear +VEGF MPs (W) and PC Shear –VEGF MPs 
(X) develop dark regions of dissimilar sizes throughout the EB populations. (scale 
bar=400μm) 
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Endothelial Gene Expression 
 After 4 and 7 days of EB differentiation, PC Shear and PC Static EBs treated with 
VEGF were analyzed for expression of endothelial marker genes Flk-1, Flt-1, VE-
cadherin, and PECAM.  Gene expression was calculated as relative fold change by 
comparing all PC Static groups to PC Static –VEGF and all PC Shear groups to PC Shear 
–VEGF.  Treatment with VEGF did not alter Flk-1 expression in PC Static EB groups at 
day 4 or 7, however, PC Shear +VEGF EBs expressed the highest levels of Flk-1 on day 
4 and day 7 compared to any other EB group (Fig. 5.2A).  Soluble or microparticle 
VEGF treatment of PC Static EBs did not alter Flt-1 expression levels at any of the time 
points examined (Fig. 5.2B).  However, PC Shear +VEGF expressed the highest levels of 
Flt-1 when compared to all other EB groups.  While, PC Shear +VEGF MPs and PC 
Shear –VEGF MPs expressed higher levels of Flt-1 than PC Shear –VEGF, there were no 
differences in Flt-1 expression between PC Shear +VEGF MPs and PC Shear –VEGF 
MPs (Fig. 5.2 B).  VE-cadherin expression was highest in PC Shear +VEGF EBs at day 4 
and 7.  PC Shear +VEGF MPs and –VEGF MPs expressed comparable levels of VE-
cadherin at day 4 (Fig. 5.2C).  After 4 days of EB differentiation, PC Shear +VEGF EBs, 
PC Shear +VEGF MPs EBs, as well as PC Shear –VEGF MPs EBs expressed 
significantly higher levels of PECAM compared to PC Shear –VEGF EBs.  However, by 
day 7 PC Shear +VEGF, PC Shear +VEGF MPs, and PC Shear –VEGF MPs EBs groups 
were significantly higher than PC Shear –VEGF and all PC Static EB groups but were 
not significantly different from one another (Fig. 5.2D).  In general, VEGF treatment of 
EBs formed from statically cultured ESCs elicited no significant changes in Flk-1, Flt-1, 
VE-cadherin, or PECAM expression.  However, VEGF treatment induced substantial 
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increases in Flk-1, Flt-1, VE-cadherin, and PECAM in EBs formed from shear pre-
conditioned ESCs, with soluble VEGF treatment causing the largest increase in 
expression of endothelial marker genes.    Even though Flk-1 and Flt-1 are VEGF 
receptors, Flk-1 expression was only higher in EBs treated with soluble VEGF that were 
formed from shear pre-conditioned ESCs, while Flt-1 expression was increased in VEGF 
treated EBs formed from shear pre-conditioned ESCs.  Interestingly, addition of unloaded 
microparticles elicited increases in Flt-1, VE-cadherin, and PECAM in EBs formed from 
shear pre-conditioned ESCs.  Overall, the results suggest that VEGF treatment enhanced 
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 EBs formed from pre-conditioned ESCs and treated with VEGF were examined 
for VE-cadherin protein expression and organization after 7 days of EB differentiation.  
PC Static –VEGF EBs displayed no detectable VE-cadherin expression (Fig. 5.3A).  
However, confocal images of PC Static +VEGF EBs suggested VE-cadherin expression 
was localized to the periphery of the EBs (Fig. 5.3B).  Similar to PC Static –VEGF EBs, 
VE-cadherin+ cells were not detected in PC Static +VEGF MPs and –VEGF MPs (Fig. 
5.3 C, D).   VE-cadherin+ cells localized at the center of PC Shear –VEGF EBs (Fig. 
5.3E), which is consistent with previous studies (Chapters 3).  In contrast, VE-cadherin 
expression was confined to the periphery of PC Shear +VEGF EBs (Fig. 5.3F).    PC 
Shear +VEGF MPs and –VEGF MPs EBs developed clusters of centrally located VE-
cadherin+ cells (Fig. 5.3G,H) which is similar to VE-cadherin+ cellular organization 
observed in PC Shear –VEGF EBs.  While confocal microscopy allows imaging within in 
3D structures, it artificially enhances fluorescence at the periphery of 3D structures.  
Therefore in order to better visualize and confirm VE-cadherin expression at the 
periphery of EBs, cryosections of EBs were assessed for VE-cadherin expression.  While, 
VE-cadherin was not detected PC Static –VEGF EBs (Fig. 5.4A), low levels of VE-
cadherin expression was detected in PC Static +VEGF, PC Static +VEGF MPs, and PC 
Static –VEGF MPs (Fig. 5.4B-D).  The VE-cadherin expression observed in the 
cryosections and confocal images were similar in PC Static +VEGF EBs.   Unlike PC 
Static –VEGF EBs, VE-cadherin expression was observed in PC Shear –VEGF EBs (Fig. 
5.4 E).  PC Shear +VEGF EBs contained a number of VE-cadherin+ cells localized to the 
periphery of the EB (Fig. 5.4F) which paralleled the VE-cadherin staining pattern 
observed in PC Shear +VEGF EBs.  VE-cadherin was expressed at low levels in both PC 
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Shear +VEGF MPs and PC Shear –VEGF MPs (Fig. 5.4 G, H).  Confocal images of PC 
Shear and PC Static EBs treated with or without VEGF demonstrated that VE-cadherin 
cellular organization and expression is modulated by method of VEGF delivery.  In 
general, soluble delivery of VEGF induced VE-cadherin expression to localize to the 
periphery of EBs, while VEGF released from microparticles appeared to have no effect 
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pVE-cadherin GFP ESCs Embryoid Body Morphology 
 
 In order to track VE-cadherin expression in shear pre-conditioned ESCs during 
EB differentiation in response to VEGF treatment, ESCs were further differentiated as 
EBs and treated with (+VEGF) or without soluble VEGF (-VEGF) or with microparticles 
loaded with VEGF (+VEGF MPs) or unloaded microparticles (-VEGF MPs).   After 7 
days of EB differentiation treatment with VEGF, differences in EB morphology were 
observed.  PC Static –VEGF EBs developed a rounded morphology and contained EBs of 
varying sizes (Fig. 5.5A).  Similarly, PC Static +VEGF EBs were heterogeneous in size 
and shape (Fig. 5.5B).  However, majority of PC Static +VEGF MPs  (Fig. 5.5C) were 
rounded, but varied in size and appeared dark in contrast to PC static –VEGF and  
+VEGF EBs.  PC Shear –VEGF EBs developed dark regions which protruded from the 
periphery of EBs (Fig. 5.5E).  Comparable to PC Shear –VEGF EBs, PC Shear +VEGF 
EBs developed optically opaque dark protrusions (Fig. 5.5 F).  PC Shear +VEGF MPs 
appeared smaller in size in comparison to PC Shear +VEGF EBs and had a more 
irregular morphology (Fig. 5.5G).  PC Shear –VEGF MPs EBs (Fig. 5.5H) displayed 
similar morphology to PC Shear +VEGF MPs EBs.  Similar to ESC EBs treated with 
VEGF, the VEGF delivery method modulated morphology of EBs formed from pre-
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VE-cadherin Localization in pVE-cadherin GFP Embryoid Bodies 
 VE-cadherin expression and localization within EBs treated with VEGF was 
assessed at day 7 by examining  GFP flourescence in EBs formed from pVE-cadherin 
GFP ESCs (VE-GFP).  Few GFP positive cells were detected in PC Static –VEGF EBs 
(Fig. 5.6 A).  On the other hand, GFP positive cells were observed on the periphery of  
PC Static +VEGF EBs (Fig. 5.6 B).  Small clusters of GFP postive cells emerged close to 
the periphery of PC Static +VEGF MPs and –VEGF MPs EBs (Fig. 5.5 C,D).  In 
constrast to PC Static –VEGF EBs, large clusters of GFP+ cells protuded from the 
periphery of PC Shear –VEGF EBs (Fig. 5.6E).  Similar GFP localization was observed 
in PC Shear +VEGF EBs with clusters of GFP+ cells close to the edge of the EB (Fig. 
5.6F).  Vastly different GFP expression was observed in PC Shear +VEGF MPs and PC 
Shear –VEGF MPs EBs with few GFP positive cells detected throughout the EB (Fig. 5.6 
G,H).  The localiztion of GFP expression in PC Shear +VEGF and PC Shear –VEGF EBs 
correlates with the localization of the dark regions observed in phase images of PC Shear 
+VEGF and PC Shear –VEGF EBs (Fig. 5.5 E,F).  Altogether, VEGF treatment of EBs 
formed from statically cultered ESCs increased expression of VE-cadherin and 
modulated localization of endothelial-like cells.  On the other hand, VEGF treatment of 
EBs formed from shear pre-conditioned ESCs appeared to have very little effect on 
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GFP Expression Analysis of Single Cells from  pVE-cadherin EBs 
 Throughout EB differentiation the percentage of  cells which expressed VE-
cadherin was tracked by analyzing GFP expression in cells dissociated from VE-GFP 
EBs treated with or without VEGF.  GFP expression anlysis of  single cells provided a 
quantitave measure of VE-cadherin positivc cells in contrast to confocal imaging which 
only reveals localization of the VE-cadherin positive cells within EBs.  GFP expression 
was examined after 2, 4, and 7 days of EB culture.  At day 2, PC Static –VEGF, PC Static 
+VEGF,  PC Static +VEGF MPs, and PC Static –VEGF MPs contained approximately 
2.5%, 2.1%, 3.4%, and 3.7%  GFP positive cells, respectively (Fig. 5.7 A-D).  However, 
by day 4 all PC Static EBs contained almost no GFP positive cells with all groups having 
less than 2% GFP positive cells (comparable to ESC control) (Fig. 5.7 E-H).  By day 7, 
there was a drastic increase in the percentage of GFP positive cells in all PC Static 
groups.  PC Static –VEGF, PC Static +VEGF, PC Static +VEGF MPs, and PC Static –
VEGF MPs EBs contained 15.0%, 17.0%, 11.2%, and 11.3% GFP positive cells (Fig. 5.7 
I-L).  The percentage of GFP positive cells in PC Shear –VEGF, PC Shear +VEGF, PC 
Shear +VEGF MPs, and PC Shear –VEGF MPs was 2.2%, 1.7%, 3.7%, and 2.8%, 
respectively (Fig. 5.7 M-P).  By day 4, no GFP+ cells were detected in any PC Shear EB 
groups (Fig. 5.7. Q-T).  Similiar to PC Static EB groups, by day 7 PC Shear EB groups 
displayed measurable increases in GFP postive cell percentages.  PC Shear –VEGF, PC 
Shear +VEGF, PC Shear +VEGF MPs, and PC Shear –VEGF MPs EBs contained cell 
populations which were 10.9%, 12.0%, 9.3%, and 8.9% GFP positive, respectively (Fig. 
5.7 U-X).  Overall, GFP expression analysis of single cells from PC Static and PC Shear 
VE-GFP EBs suggests that treating EBs with soluble VEGF increased the percentage of  
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endothelial-like cells, while the presence of microparticles decreased the percentage of 
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 These studies revealed that VEGF treatment and delivery strategy (soluble or via 
microparticles) of EBs formed from pre-conditioned (+/- shear) ESCs modulates 
endothelial-like cell organization and endothelial differentiation.  EBs formed from VE-
cadherin GFP reporter ESCs were also treated with VEGF in order to directly assess the 
effects of VEGF on VE-cadherin expression and localization.  Differences in EB 
morphology were observed in PC Static –VEGF EBs in comparison to PC Static +VEGF 
MPs and PC Static –VEGF MPs with the presence of variable sized dark regions.  PC 
Static +VEGF MPs and PC Static –VEGF MPs displayed similar morphology, which 
suggests the presence of microparticles alone, irrespective of VEGF, induced different 
EB morphology.  PC Shear –VEGF EBs developed morphology consistent with PC Shear 
EBs observed in chapter 4.  However, when PC Shear EBs were treated with soluble 
VEGF for 7 days, optically opaque regions were no longer observed suggesting that 
VEGF modulated morphogenesis of shear pre-conditioned ESCs within the EBs.  The 
dark regions observed in PC Shear +VEGF MPs and PC Shear –VEGF MPs EBs 
demonstrated that the presence of microparticles did not affect the EB morphology 
generally observed in EBs formed from shear pre-conditioned ESCs. 
 Evaluation of endothelial marker genes Flk-1, Flt-1, VE-cadherin, and PECAM, 
revealed large differences in VEGF effects on endothelial differentiation in PC Static EBs 
and PC Shear EBs.  Treating PC Static EBs with VEGF did not stimulate significant 
differences in the 4 endothelial marker genes examined.  However, VEGF soluble 
treatment of PC Shear EBs generated large increases in expression of all four endothelial 
genes.  PC Shear +VEGF EBs displayed the most drastic increase in Flk-1 compared to 
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PC Shear –VEGF EBs.  PC Shear +VEGF EBs and PC Shear –VEGF EBs expressed 
significantly higher levels of Flt-1, VE-cadherin, and PECAM when compared to PC 
Shear –VEGF EBs.  However, these genes were expressed at similar levels in both EB 
groups suggesting that the presence of the microparticles and not VEGF elicited the 
increase in gene expression.  Studies that incorporated microparticles formed from 
different subtypes of extracellular matrices within EBs demonstrated differences in 
differentiation profile [177].  The disparity in changes in endothelial gene expression in 
response to VEGF stimulation between PC Static and PC Shear EB groups could be due 
to the variation in the number of cells that have VEGF receptors.  Results from Chapter 3 
as well as other published studies reveal that the expression of VEGF receptors, Flk-1 
and Flt-1, is higher in ESCs pre-conditioned with shear in contrast to ESCs cultured 
under static conditions [81, 85, 148].  Differences in endothelial gene expression of PC 
Shear +VEGF EBs and PC Shear +VEGF MPs EBs could be due to the variance in 
VEGF concentrations delivered to the EBs.  EBs were treated with 50 ng/ml VEGF every 
2 days while microparticles released less than 5 ng/ml over 7 days.  However, the 
majority of VEGF is released in the first 24 hours during initial EB formation (see 
Appendix C) [178].  Even though, 10 times less VEGF was delivered to PC Shear 
+VEGF EBs significant increases in endothelial marker genes were still observed.   
 VE-cadherin positive cellular localization within PC Shear EBs was altered by 
VEGF.  VE-cadherin expression in PC Shear +VEGF EBs was localized to the outer edge 
of EBs while VE-cadherin expression in PC Shear –VEGF EBs localized to the center of 
the EB.  Soluble growth factor diffusion within EBs is limited by the tight connections 
between cells on the outermost layer of the EB[175].  Therefore, VEGF is most likely 
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only stimulating endothelial differentiation in the outermost layer of the EB. 
Additionally, PC Shear +VEGF EBs are formed in the presence of VEGF which may also 
be affecting initial localization and aggregation of VE-cadherin positive cells.  Cellular 
aggregation is mediated by the presence of soluble factors and cytokines as was 
demonstrated in hepatocytes exposed to soluble epidermal growth factor [179] and blood 
cells treated with a combination of cytokines including  erythropoietin, thrombopoietin, 
and stem cell factor [180].  The VEGF released from microparticles did not alter VE-
cadherin positive cellular organization within PC Shear EBs.  Additionally, the 
comparable VE-cadherin cell patterning in PC Shear –VEGF, PC Shear +VEGF MPs, 
and PC Shear –VEGF MPs suggests that the quanitity of VEGF released from the 
microparticles was not sufficient to induce any unique VE-cadherin cellular organization. 
 In order to directly measure VE-cadherin expression and observe VE-cadherin 
cellular organization in response to VEGF within PC Shear and PC Static EBs and 
confirm the results observed using ESCs, an ESC VE-cad GFP reporter cell line was used 
for similar studies.  In this study, PC Shear VEGFP –VEGF EBs developed dark regions 
that protruded from the edge of the EBs unlike PC Shear –VEGF EBs in wildtype D3 
ESCs, which developed dark foci at the center of the EBs.  Soluble VEGF treatment had 
different effects on VE-cadherin cellular organization within PC Shear +VEGF EBs and 
PC Shear +VEGF VE-GFP EBs.  PC Shear VEGFP + VEGF EBs maintained a similar 
VE-cadherin expression pattern compared to PC Shear VEGFP –VEGF EBs.  While VE-
cadherin+ cells were not observed in confocal images of PC Static +VEGF, PC Static 
+VEGF MPs, and PC Static –VEGF MPs, VE-cadherin+ cells were observed in all PC 
Static VE-GFP EB groups.  In general, GFP expression analysis of all PC Static VEGFP 
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and PC Shear VEGFP EB groups revealed that on day 2 all samples contained some 
endothelial-like cells.  However, by day 4 few endothelial-like cells were detected and by 
day 7 greater than 8% of the cells were endothelial-like.  These results taken together 
with confocal images of day 7 VE-GFP EBs suggest that VE-cadherin+ cells within PC 
Static VEGFP EBs were dispersed throughout the EB unlike the clustering of VE-
cadherin+ cells observed in PC Shear –VEGF VE-GFP EBs and PC Shear +VEGF VE-
GFP EBs.  Altogether, this suggests that soluble VEGF treatment elicited increases VE-
cadherin expression, while the presence of micorparticles decreased VE-cadherin 
expression.   The results of the VE-GFP ESC studies do not confirm the results obtained 
in the ESC studies. 
 In this study, 50 ng/ml of VEGF was used to treat EBs because established 
protocols that derive endothelial cells from ESCs generally use similar VEGF 
concentrations of 50 ng/ml over a 3 week culture period [54, 56].  However, soluble 
diffusion of growth factors within EBs has been demonstrated and reported to be limited 
by the outer cell layer [175].  Therefore, these studies explored another method of 
delivering VEGF by incorporating gelatin microparticles, which can release VEGF 
within the EB microenvironment.  This strategy of VEGF delivery overcomes the 
challenges of molecule diffusion through the outer layer of the EB and allows for control 
of local release of VEGF to cells within the EB.  While gelatin microparticles have been 
utilized as a delivery vehicle for several factors such as BMP2, TGF-β, and IGF [178, 
181-183], few studies have delivered factors to stem cell aggregates via microparticles 
[174, 183]. The similarities in the increases of endothelial marker gene expression in 
VEGF loaded and VEGF unloaded treated EBs formed from shear pre-conditioned 
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suggested that the VEGF released from the microparticles had less of an effect on 
differentiation than the mere presence of microparticles within the EB.  Incorporation of 
unloaded microparticles formed from different materials within pluripotent stem cell 
aggregates elicited different differentiation profiles [177] compared to pluripotent stem 
cell aggregates not containing microparticles.  Recent studies have demonstrated that 
ESCs produce factors that can enhance somatic cell survival, increase neovascularization, 
and promote endothelial differentiation [184-186].  The significant increase in endothelial 
gene expression in PC Shear -VEGF MPs EBs compared to PC Shear –VEGF EBs may 
be due to the presence of micropaticles as well as differences in growth factor production 
between EB populations.   
 
Conclusion 
 Soluble VEGF treatment of EBs formed from shear pre-conditioned ESCs elicited 
changes in endothelial marker gene expression, organization, and EB morphology.  The 
mere presence of gelatin microparticles in shear pre-conditioned EBs promoted 
endothelial differentiation but has little effect on endothelial cellular organization and 
morphogenesis.  The quantities of VEGF delivered via microparticles may not have been 
sufficient to promote endothelial differentiation to the extent of the VEGF quantities used 
for soluble VEGF treatment.  Priming ESCs with fluid shear prior to EB differentiation 
mediated ESC responses to VEGF stimulation.  However, treating EBs formed from 
shear pre-conditioned ESCs with VEGF did not substantially enhance the number of 
endothelial-like cells within the EBs.  These studies suggest that the soluble factor 
delivery strategy to EBs modulates stem cell organization and differentiation potential.  
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HYPOXIA EFFECTS ON VASCULOGENESIS OF FLUID SHEAR 
STRESS PRE-CONDITIONED EMBRYONIC STEM CELLS 
 
Introduction 
 Low oxygen or hypoxic conditions are present throughout many physiological 
environments, disease pathologies, and during embryonic development [19, 104-107].  
While cells are generally maintained and cultured at 21% oxygen (normoxic) in vitro, in 
vivo cells develop and function at oxygen levels  generally ranging from 1-10% 
(hypoxic) [19].  Oxygen levels play a very important role in many cellular processes 
including but not limited to metabolism, differentiation, proliferation, and tissue 
morphogenesis, [19, 108-110].  More specifically oxygen levels play a critical role in 
vascular development and differentiation during embryogenesis[19, 24, 111]. 
 Prior to the development of the circulatory system embryonic oxygen levels are 
approximately 3% O2 [114, 121].  Low oxygen tension is imperative for proper 
morphogenesis and function of the cardiovascular system in the early embryo [122].  
Oxygen constitutes an integral micronvironmental cue which is critical for endothelial 
and vascular development [122, 125].  Oxygen levels within the embryo range from 1-
3% [114, 121] indicating that embryogenesis occurs in a hypoxic environment.  During 
development, oxygen gradients develop across embryos which are responsible for 
patterning and formation of the cardiovascular system [19, 122].  Additionally, oxygen 
modulates cellular VEGF production in vivo [123, 124] as well as in vitro [187].  In vitro, 
hypoxia has been utilized to differentiate stem cells into, cardiac [188] and vascular 
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progenitors [189].  Low oxygen may provide instructive cues for endothelial 
differentiation and vasculogenesis within EB microenvironments. 
Fluid shear stress also plays an important role in the development of the 
cardiovascular system, which is the first functioning physiological system to be 
established within the embryo [16, 17].  Gene and protein expression patterns which 
develop in the embryonic cardiovascular system are regulated by fluid shear stress, and 
disruption of fluid flow can lead to abnormal cardiogenesis [17, 20]  Eventhough the 
initial embryonic vascular networks, yolk sac and trunk axial vessels, develop prior to the 
onset of blood flow, fluid shear stress imparted by blood flow is vital to the maturation 
and stabilization of the primitive embryonic vasculature [21].  In vivo, fluid shear stress 
is vital for the proper development of the cardiac, vascular, and hematopoietic system, 
demonstrating the instructive potential of this physical force to promote vasculogenesis in 
vitro.   
Based on the results from chapters 3 and 4 in which fluid shear stress pre-
conditioned ESCs form EBs develop a core of endothelial like-cells (VE-cadherin+), this 
study aimed to use hypoxia to modulate endothelial differentiation and vasculogenesis in 
EBs formed from shear pre-conditioned ESCs.  EBs formed from (+/- shear) pre-
conditioned ESCs were cultured under normoxia (21%) or hypoxia (3%) for 7 days and 
then assessed for morphology, endothelial gene and protein expression, VEGF gene and 
protein production, as well as hypoxia inducible factor A gene and protein expression 
during EB differentiation.  This study indicates that fluid shear and hypoxia modulate 
primitive vascular formation as well as angiogenic factor production within EBs.  
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Therefore, providing a new strategy to pre-vascularize stem cell based constructs which 




ESC and EB Culture 
D3 and D3 pVE-cadherin GFP murine embryonic stem cells were cultured using 
methods previously described in Chapter 3. EBs were cultured as previously described in 
Chapter 3 under normoxic (21% O2, 5% CO2) or hypoxic (3% O2, 5% CO2) conditions. 
 
LIVE/DEAD Cell Viability Assay 
Following 2, 4, and 7 days of EB differentiation, cell viability was assessed using 
LIVE/DEAD staining (Invitrogen).  EBs were incubated under gentle agitation in phenol 
red- free, serum-free medium containing 1uM calcein AM and 2uM ethidiumhomodimer 
I at room temperature for 30min.  EBs were then washed three times with PBS (w/o Ca2+ 
and Mg+) and immediately imaged using a Ziess LSM 510Multiphoton confocal 
microscope. 
 
Total Protein Quantification Assays 
The total protein content of day 7 EBs was determined using a bicinchonic assay 
(BCA, Thermo).  EBs were lysed using 200 μL TPER buffer (Thermo) with rotation for 
30 min at room temperature followed by 5 minutes of centrifugation at 14,000 RPM to 
remove particulate.  Total protein content was analyzed using a bicinchoninic acid (BCA) 
assay kit (Pierce).   25 μl of sample was incubated with BCA solution for 30 minutes. 
Bovine serum albumin diluted in TPER was used as to generate a standard curve (0 
µg/mL - 2,000 µg/mL).  Absorbance readings were taken at 562 nm using  a SpectraMax 
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M2e plate reader.  The absorbance readings of the EB lysate samples were compared 
against the standard to calculate absolute protein concentrations. 
 
VEGF Quantity Protein Analysis 
Enzyme-linked immunosorbent assay (ELISA) kits (DuoSet, R&D Systems).  
were used to quantify the amount of VEGFA produced day 7 EBs.  EBs were lysed using 
200 μL TPER buffer (Thermo) with rotation for 30 min at room temperature followed by 
5 minutes of centrifugation at 14,000 RPM to remove particulate.  Briefly, capture 
antibody was adsorbed onto a MaxiSorp™ Immuno 96-well plate (Nunc), followed by a 
blocking step, incubation with 100 μL sample, and binding of analyte to a biotinylated 
detection antibody. The concentrations of capture and detection antibodies used were 
dictated by the DuoSet protocol for each protein: 400 ng/mL and 100 ng/mL.  TPER 
buffer was used as the diluent for the standard curve samples.  The amount of analyte was 
assessed using the colorimetric reaction of peroxidase and tetramethylbenzidine (TMB) 
with an absorbance reading at 450 nm.  The absorbances for each sample were compared 
to the standard curve to establish the protein analyte content, which was normalized to 
the total protein in the EB lysate determined from the total protein quantification assay. 
 
SDS-PAGE and Western Blotting 
Sample protein concentration was determined using the aforementioned BCA 
Protein Quantification kit (Pierce); equal amounts of protein (≈80 µg) per sample were 
mixed with loading buffer (0.1 M Tris-HCl containing SDS, glycerol, biomophenol blue, 
and 2-mercaptoethanol), heatedat 95°C for 5 minutes, and loaded in 7.5% Tris-HCl 
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polyacrylamide precast gels (Bio-Rad).  Vertical electrophoresis was performed using a 
Mini-PROTEAN Tetra Cell system with SDS/PAGE running buffer (Tris 
base/glycine/SDS solution) run at 100V for 1 hour to separate the protein samples by 
molecular weight.  A protein ladder (Precision Plus Protein Kaleidoscope, 10-250kD, 
Bio-Rad) was loaded into each gel as a reference for protein products. 
 Following SDS PAGE separation, gels were removed from the electrophoresis 
tank and loaded into transfer cassettes.  Gels were placed directly beside a PVDF 
membrane (Fisher Scientific) and sandwiched between filter paper within the cassettes to 
allow for protein transfer from the gel onto the PVDF membrane.  Protein transfer was 
run in transfer buffer overnight at 4°C with 30V.  Once protein transfer was complete, 
membranes were removed and equilibrated in PBS prior to immunostaining.  Blots were 
stained using the Snap ID system (Bio-Rad).  Membranes were placed in Snap ID 
staining wells, and IR blocking medium (30 mL per well, Rockland) was pulled through 
the well by vacuum.  Membranes were then incubated with primary antibodies for HIF1a 
(1:100),and anti-β-actin (loading control, 1:300)over night at 4°C.  Primary antibody 
incubation was followed by continuous vacuum rinse with 0.01% Tween-20/PBS 
solution, and membranes were incubated with IR secondary antibodies (680 anti-goat and 
800 anti-rabbit, 1:5000, LiCor), followed by continuous vacuum rinse with 30 mL 
PBS/0.1% Tween-20 solution.  Stained membranes were removed from the staining wells 
and rinsed 2 more times in PBS with gentle rocking for 10 minutes at room temperature.  





Embryoid Body Morphology 
EBs were formed from (+/- shear) pre-conditioned ESCs and cultured under 
normoxic (21%) or hypoxic (3%) conditions for 7 days and assessed for viability.  During 
EB differentiation EBs formed from statically cultured ESCs displayed similar 
morphology under both oxygen conditions at day 4 (Fig. 6.1A, B).  Day 4 EBs formed 
from shear pre-conditioned ESCs cultured under hypoxia and normoxia appeared dark, 
however, PC Shear hypoxia EBs appeared larger in size compared to PC Shear normoxia 
EBs (Fig. 6.1C,D).  PC shear hypoxic EBs appeared larger in size and developed 
optically opaque dark regions which covered approximately 70% of the EB.  By day 7, 
PC static normoxia and PC static hypoxia EBs exhibited similar morphology (Fig. 6.1E, 
F).  However, after 7 days of EB differentiation distinct differences in PC shear normoxia 
and PC shear hypoxia morphology were apparent with dark regions present at the center 
of PC shear normoxia EBs (Fig. 6.1G).  PC shear hypoxia EBs contained dark regions as 
well however, unlike the dark regions in PC Shear normoxia EBs, these dark regions 
varied in size, optical opaqueness, and did not localize to the center of EBs (Fig. 6.1H).  
After 7 days of EB culture distinct differences in cell death were not observed between 
hypoxac and normoxia EB groups (Fig. 6.1-L).  Overall the data suggested that hypoxia 
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Endothelial Gene Expression 
  
Endothelial differentiation of EBs was assessed by examining Flk-1, Flt-1, VE-
cadherin, and PECAM gene expression after 4 and 7 days of hypoxia culture.  Flk-1 gene 
expression was similar in normoxia and hypoxia EB samples at day 4, however on day 7 
Flk-1 was higher in both PC static hypoxia and PC shear hypoxia EBs as compared to PC 
static normoxia and PC shear normoxia EBs, respectively (Fig. 6.2A).  Similarly, Flt-1 
expression levels were not significantly altered on day 4, but by day 7 when PC static 
hypoxia EBs expressed higher levels of Flt-1 than PC static normoxia EBs and PC shear 
hypoxia EBs expressed higher levels of Flt-1 than PC shear normoxia EBs (Fig. 6.2B). 
VE-cadherin was also expressed at similar levels in normoxia and hypoxia EB groups on 
day 4.  At day 7, EBs cultured under hypoxic conditions expressed higher levels of VE-
cadherin than EBs cultured under normoxia (Fig. 6.3C).  PECAM gene expression was 
only increased under hypoxia in D7 PC static EBs (Fig. 6.3D).  The increased expression 
of endothelial genes Flt-1, Flk-1, and VE-cadherin at day 7 in EBs cultured under 
hypoxia suggested that hypoxia promoted endothelial differentiation in EBs.  
Additionally, long term culture under hypoxia is required to promote endothelial 
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VE-cadherin Protein Expression  
 Endothelial cell organization was analyzed by assessing VE-cadherin expression 
and patterning in normoxic and hypoxic EBs formed from pre-conditioned (+/- shear) 
ESCs.  After 2 days of EB formation VE-cadherin+ cells were not detected in PC static 
normoxia EBs (Fig. 6.3A), PC static hypoxia EBs (Fig. 6.3B) or PC shear hypoxia EBs 
(Fig. 6.3D).  However, VE-cadherin was detected in PC shear normoxia EBs (Fig. 6.3C).  
By day 4, only for PC static normoxia EBs were negative for VE-cadherin (Fig. 6.3E).  
PC static hypoxia, PC shear normoxia, and PC shear hypoxia EBs developed clusters of 
VE-cadherin+ cells at the interior of the EB.  By day 7 each EB group developed 
markedly different VE-cadherin cellular organization.  PC static normoxia EBs remained 
negative for VE-cadherin (Fig. 6.3I) while the VE-cadherin expression is not only found 
in the center but also close to the periphery of the PC static hypoxia EBs (Fig. 6.3J).  Day 
7 PC shear EBs under normoxia and hypoxia develop significantly different VE-
cadherin+ cell organization (Fig. 6.3 K, L).  VE-cadherin+ cells remain at the center of 
PC shear normoxia EBs, while VE-cadherin+ cells organize into primitive networks 
which radiated from the center of PC shear hypoxia EBs.  The VE-cadherin+ cellular 
organization observed at day 7 in hypoxia EBs correlated with increased expression of 
endothelial genes Flk-1, Flt-1, and VE-cadherin.  Altogether, these results demonstrate 
that hypoxia and fluid shear stress pre-conditioning played a role in endothelial-like cell 
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Hypoxia Inducible Factor A Expression  
 HIF1α gene and protein expression were examined in EBs formed from (+/- 
shear) pre-conditioned ESCs cultured under normoxic or hypoxic conditions.  Following 
4 days of EB differentiation PC static normoxia EBs expressed less HIF1α than PC static 
hypoxia EBs (Fig. 6.4A).  In contrast, D4 PC shear normoxia EBs had a significantly 
higher expression of HIF1α than D4 PC shear hypoxia EBs (Fig. 6.4A).  By day 7 PC 
static normoxia EBs expressed higher levels of HIF1αthan PC static hypoxia EBs (Fig. 
6.4A).  Interestingly, in day 7 shear normoxia EBs HIF1α was not detected in majority of 
samples, however in day 7 shear hypoxia EBs HIF1α expression levels were similarly 
low in all samples (Fig. 6.4A). Analysis of relative fold change of HIF1α expression 
through qRT-PCR did not display drastic changes in PC Static hypoxia or PC Shear 
hypoxia EBs at days 4 and 7 (Fig. 6.4B).  HIF1α protein expression is highest in day 7 
PC static hypoxia EBs compared to all other EB groups (Fig. 6.4C).  The HIF1α gene and 
protein expression results suggest that under normoxia HIF1α EB expression was 
variable and transient.  However, long term exposure to hypoxia elicited uniform HIF1α 
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VEGFA Gene and Protein Expression 
 
VEGFA gene expression was analyzed in D4 and D7 PC static/shear 
normoxia/hypoxia EBs. VEGFA protein expression in D7 PC static/shear 
normoxia/hypoxia EBs was also evaluated.  After 4 days of EB differentiation.  VEGFA 
gene expression did not change significantly compared to EBs cultured under hypoxic 
conditions compared to EBs cultured under normoxia (Fig. 6.5A).  However, by day 7, 
PC static hypoxia EBs and PC shear hypoxia EBs expressed significantly higher levels of 
VEGFA than PC static normoxia EBs and PC shear normoxia EBs, respectively (Fig. 
6.5A).  Additionally, by day 7, PC shear hypoxia EBs expressed higher levels of VEGFA 
protein compared to PC static hypoxia and PC shear normoxia EBs (Fig. 6.5B).  No 
VEGFA protein was detected in the EB conditioned media for any of the groups studied.  
Altogther this suggests that VEGFA produced by EBs was retained within the EB 
mircoenvironment.  VEGFA gene and protein expression results suggest that hypoxia 
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VE-cadherin GFP Embryoid Bodies  
 Endothelial differentiation was examined during hypoxia culture of EBs by pre-
conditioning VE-cadherin GFP reporter ESCs and then assessing their GFP fluorescence 
at day 2, 4, and 7 of EB differentation.  Following 2 days of EB culture, the observed 
mean GFP flourescence intensity was highest in PC Shear normoxia EBs compared to all 
other EB groups.  However, by day 4 the mean GFP fluorescence was not different in 
cells from PC Static normoxia and PC Shear normoxia EBs.  At day 4, the mean 
fluorescence intensity of cells in PC Static hypoxia EBs and PC Shear hypoxic EBs was 
less than PC Static normoxia EBs and PC Shear normoxia EBs, respectively.  Following 
7 days of EB culture, the mean fluorescence intensity of cells in PC Static hypoxia EBs 
was markedly higher than cells from PC Static normoxia and PC Shear normoxia EBs 
(Fig. 6.6A).  Percentage of VE-cadherin cells within EB populations was also assessed 
throughout EB differentiation.  Similar to the GFP mean fluorescence intensity, on day 2 
PC Shear normoxia EBs had the highest percentage of VE-cadherin positive cells in 
comparison to all other EB groups (Fig. 6.6B-F).  By day 4, 5.7  ± 2.8% and 7.0 ± 0.8% 
of the cells were VE-cadherin positive in PC Static normoxia and PC Shear normoxia 
EBs, respectively (Fig. 6/6 Q,I).  In contrast, EBs exposed to PC Static hypoxia and PC 
Shear hypoxia EBs had less than 2% of the cells that were positive for VE-cadherin (Fig. 
6.6 H, J).  However, after 7 days of EB culture 58.0 ± 9.7% and 10.7 ± 2.5% of the cells 
were VE-cadherin positive in PC Static hypoxia EBs and PC Shear hypoxia EBs, 
respectively (Fig. 6.6B, K-N).  Altogether the results suggest that oxygen modulated VE-
cadherin expression differently in EBs formed from statically cultured ESCs and shear 
pre-conditioned ESCs.  Additionally, these results indicate that long term culture under 
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low oxygen elicited higher expression of endothelial marker genes compared to short 
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 This study demonstrated that hypoxia microenvironments promoted endothelial 
differentiation and vasculogenic events as well as enhanced ESC VEGFA production.  
EBs formed from fluid shear stress pre-conditioned ESCs developed primitive vascular 
networks when cultured under low oxygen.   Additionally, the combination of fluid shear 
pre-conditioning and low oxygen induced EBs to produce increased levels of VEGF 
compared to EBs formed from ESCs cultured statically and under hypoxic conditions.  In 
general, hypoxic microenvironments promoted vascular differentiation within EBs.   
 The morphological differences observed between EB groups cultured under 
hypoxia and normoxia at day 7 correlate with the differences in VE-cadherin+ cell 
patterning and organization observed at similar time points.  PC static normoxia EBs did 
not develop any dark regions as well as any detectable VE-cadherin+ cell staining and a 
subset of PC static hypoxia EBs developed dark regions as well as some organization of 
VE-cadherin+ cells.  On the other hand, PC shear normoxia EBs developed dark regions 
at the centroid of the EB similar to the morphology observed in chapters 3 and 4 as well 
as centrally located clusters of VE-cadherin+ cells.  Most interestingly, PC shear hypoxia 
EBs developed optically opaque regions markedly larger than the optically opaque 
regions observed in PC shear normoxia EBs which correlated with the organization of 
VE-cadherin+ cells in complex networks.  While both PC shear and PC static EBs 
cultured under hypoxic conditions contained populations of vascular cells, the formation 
of primitive vasculature within PC shear hypoxia EBs may be due to the enhanced 
production of the angiogenic factor VEGF.   VEGF stimulates endothelial differentiation 
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and vasculogenesis and is a critical molecule for vasculogenesis during embryonic 
development [92, 93]. 
 Comparing live/dead staining of normoxia and hypoxia EBs indicated no 
detrimental effects of low oxygen on ESC viability within EBs.  This observation 
parallels other research suggesting that hypoxia promotes expression of pro-survival 
genes and proteins to prevent cellular death [127, 190].  Furthermore, while 3% oxygen 
was a significantly lower oxygen level than 21%, 3% oxygen is more representative of 
the oxygen environment ESCs would experience in vivo [19].    
Endothelial gene expression was significantly increased in both PC static and PC 
shear hypoxia EBs suggesting that hypoxia, irrespective of pre-treatment of ESCs prior to 
EB formation, has significant effects on endothelial differentiation.  However, these 
effects were not pronounced until day 7 suggesting that long term culture under hypoxia 
is necessary to modulate vascular differentiation and vasculogenesis.  Other studies 
examine effects of hypoxia on EB differentiation culture EBs at oxygen levels ranging 
from 1-10% for periods of 7-16 days [24, 191, 192].  However while these studies 
demonstrate incresesed EB endothelial differentiation and vasculogenesis through 
endothelial gene and protein expression and angiogenic sprouting assays [24, 191], the 
studies presented here are unique as they illustrate primitive vascular formation in EBs 
cultured under hypoxia.  
 HIF1α, a transcription factor stabilized under hypoxic conditions which regulates 
numerous genes responsible for cellular adaptive responses to low oxygen [193-195], was 
expressed at some level in all EB groups in both normoxia and hypoxia. The presence of 
HIF1α in EB groups under normoxic conditions suggests that oxygen gradients exist in 
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the EB microenvironment [196, 197].  These oxygen gradients may be due in part to EB 
size causing lower oxygen levels at the center of  larger EBs [197].  Stem cell aggregate 
size regulates differentiation potential [198-201] because differentiation is influenced by 
temporal and spatial cell-cell interactions.  After 4 days of hypoxia culture EBs formed 
from shear pre-conditioned ESCs were noticeably larger in size compared to all other EB 
groups. This increase in EB size may have played a role in endothelial-like cell network 
formation as well as increased VEGF production only observed in this EB groups at day 
7.  Studies have reported that HIF1α is responsible for upregulation of VEGF receptors 
(Flk-1 and Flt-1) and is important for initiation and stabilization of vasculature during 
embryonic development [121, 122].  Furthermore, HIF1α regulates production of VEGF 
under hypoxic conditions by binding to its promoter region thereby increasing VEGF 
expression [114, 121].   The HIF1α signaling pathway played a role in increased VEGF 
production in trophoblastic cells cultured under hypoxia [187]. Overall, the increased 
expression of endothelial genes and primitive vascular network formation in PC shear 
hypoxia EBs demonstrated the critical role of hypoxia, HIF1α, VEGF receptors, and 
VEGF in vasculogenesis within EBs. 
 PC Shear hypoxia EBs produced VEGFA at magnitudes similar to the quantities 
typically used in protocols to derive ECS from ESCs [45, 56, 149].  Hypoxic conditions 
have mediated increase in VEGF production in a number of cells including vascular 
smooth muscle cells[202], hepatic cells[203]and fibroblasts [204].  The coincident 
increase in VEGFA production with expression of HIF1α parallels other studies which 
demonstrated that HIF1α activation VEGF is mediated by HIF1α stabilization via 
hypoxia[114].  This study revealed that exposing stem cells to 7 days of low oxygen can 
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result in over 50% of the cells expressing VE-cadherin and parallels a previous study 
which reported increases in stem cell vascular differentiation efficiency when cultured at 
low oxygen [189].  The results of this study suggest that exposing ESCs to hypoxic 
microenvironments can be used as an alternative to supplementing ESCs with VEGF in 




 Overall, this study demonstrates that hypoxia microenvironments modulate EB 
morphogenesis, VE-cadherin positive cell patterning, endothelial differentiation, HIF1α 
expression, and angiogenic factor production.  Moreover, in combination with fluid shear 
stress pre-conditioning, hypoxia elicited primitive vascular network formation and 
increased production of angiogenic factor, VEGF.  Priming ESCs with fluid shear stress 
prior to EB differentiation under hypoxic conditions yielded EBs which recapitulate 
aspects of embryonic vascuogenesis.  Interestingly, hypoxia elicited similar endothelial 
marker gene expression profiles in EBs formed from statically cultured ESCs and shear 
pre-conditioned ESCs suggesting that priming ESCs with fluid shear does not modulate 
ESC endothelial differentiation under hypoxic conditions but demonstrates that oxygen 






 This body of work examined the subsequent effects of fluid shear stress pre-
conditioning on embryonic stem cell (ESC) endothelial and vascular differentiation 
within embryoid bodies (EBs).  Additionally, these studies investigated the effects of 
vasculogenic cues, fluid shear stress, vascular endothelial growth factor (VEGF) and 
hypoxia on EB vascular differentiation.  Fluid shear stress has been established as a 
method to initiate endothelial differentiation in many stem cell populations; however, this 
work determined the role of fluid shear stress in endothelial differentiation commitment 
of ESCs long after cells have been subjected to this mechanical stimulation.  In vivo fluid 
shear stress, hypoxia, and VEGF play critical roles in establishing the vascular system 
within the developing embryo; however few studies have examined these cues in 
combination in vitro in the EB model. 
 Fluid shear stress has been proposed as a new means to generate endothelial cells 
from ESCs because of the number of studies demonstrating its ability to promote an  
endothelial cell (EC) phenotype in ESCs [81, 148, 205].  In order to definitively 
determine if fluid shear stress is a better method derived ECs from ESCs compared to 
standard protocols, direct comparisons of the quantities and quality of the ECs generated 
by fluid shear stress and established protocols which use a myriad of growth factors and 
cell sorting procedures need to be made [45, 55, 56, 86].  Additionally, the mechanism by 
which ESCs respond to fluid shear stress which leads to changes in phenotype need to be 
better characterized and well understood.  The studies presented in this thesis 
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demonstrate that while applying fluid shear stress to an entire monolayer of ESCs only a 
subset of ESCs develop an EC phenotype. Furthermore, similar studies have 
demonstrated that approximately 30-40% develop an EC phenotype [148].  On the other 
hand, more recent studies have claimed that fluid shear stress also leads to self renewal of 
ESCs rather than increased differentiation towards a vascular cell type [206].  Examining 
how ESCs respond to fluid shear stress and how this physical stimulation switches the 
ESC fate to differentiate or self renew needs to be elucidated. 
 The aforementioned studies focused on shearing ESCs on collagen type IV coated 
glass slides.  While different shear magnitudes were examined, different extracellular 
matrices and substrates were not investigated. In the vasculature endothelial cells are 
exposed to collagen type IV; however the mechanical properties of the vasculature are 
drastically different from glass.  In order to better recapitulate the vascular 
microenvironment, biomaterials which have comparable mechanical properties (i.e. 
elastic modulus) need to be explored.  Research examining the effects of varying 
mechanical properties such as elastic modulus on stem cell behavior and differentiation is 
expanding while also receiving some controversial debate [207-210].  Biomaterials which 
allow for tuning of mechanical properties present some challenges because they rely on 
the use of synthetic biomaterials which use harsh crosslinking agents [211] or yield 
materials which require extensive chemical modification to ensure adsorption of 
extracellular matrices and proper cell attachment. 
 The patterning of endothelial-like cells within EBs following shear pre-
conditioning suggests that mechanical stimulation of ESCs prior to EB formation may be 
used as a method to control cellular patterning and organization within 3D cell 
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aggregates.  Patterning of cells on 2D substrates has been well studied using extracellular 
matrices, biomaterials, chemokines, growth factors, and/or cytokines [206, 212].  
However, few in depth studies on patterning stem cell populations in 3D structures have 
been performed due to challenges of controlling the presentation of growth factors or 
extracellular matrices in a more complex structure.   Using physical forces which mimic 
physiological forces can potentially overcome these challenges.  For examples, strain has 
been reported to promote stem cells to differentiate into smooth muscles cells [213].  
Additionally, low magnitudes of fluid shear stress promote hematopoietic differentiation 
[89].  Subjecting different populations of stem cells to prescribed physical stimulation 
and then forming 3D cellular aggregates (strained stem cells=smooth muscle cells and 
sheared stem cells=endothelial cells) may lead to enhanced morphogenic events which 
mimic in vivo morphogenic processes. 
 During embryogenesis fluid shear stress plays a critical role in the development of 
vasculature and differentiation of endothelial cells.  While VE-cadherin positive cells 
developed a more mature endothelial phenotype with expression of vWF, imparting shear 
stress to these cells within the embryoid body may have further increase maturation, 
expansion and proliferation of these endothelial-like cells, or organization into primitive 
vasculature.  Typically, standard EB suspension culture systems generally only impart 
fluid shear stresses to the periphery of the EBs [76, 214], therefore only cells on the 
outermost layer are experiencing fluid shear stresses.  Perfusion culture could be utilized 
in order to impart fluid shear stress within the EB.  Novel technologies such as 
microfluidic chambers and flow systems [215, 216] could be employed to impart fluid 
shear stress through the interior of the EB. 
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 Cadherins ensure that cells within tissues bind to one another and mediate 
selective cell adhesions.  Like cadherins only bind like cadherins giving rise to specific 
cadherin expression in each tissue [163, 217]. For example E-cadherin is only expressed 
in epithelial tissues, N-cadherin is specific to neurons, and M-cadherin is restricted to 
myotubes.  This cadherin specificity can be used to pattern in vitro 3D stem cell 
aggregates which better mimic tissue organization and morphogenesis observed during 
embryogenesis.  Pre-conditioning stem cells with different growth factors, culturing them 
in microenvironments, or stimulating them with physical forces to promote specific 
cadherin expression and then forming 3D aggregates may be a potential method to 
generate in vitro stem cell aggregates which better recapitulate embryogenesis. 
 VEGF delivery within EBs through the use of gelatin microparticles increased 
endothelial gene expression. Surprisingly, incorporation of empty gelatin microparticles 
also increased endothelial gene expression of EBs to similar levels.  These results 
indicated that the VEGF released from the gelatin microparticles had no effect on 
endothelial differentiation of EBs.  During incorporation of microparticles within EBs, 
the microparticles were being agitated due to the rotary suspension culture used to form 
EBs.  This agitation could have stimulated the release of VEGF.  Additionally, the 
interaction of VEGF and the gelatin microparticles may have been weak because VEGF 
absorption to gelatin microparticles occurs via electrostatics since VEGF is positively 
charged and gelatin is negatively charged.  Therefore, similar results observed for VEGF 
loaded microparticles and empty microparticles could be due to the rotary agitation as 
well as weak interactions between the VEGF and the gelatin.  In order to overcome these 
challenges allowing microparticles to incorporate within EBs in the absence of rotary 
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suspension could be performed by utilizing forced aggregation.  This method forces cells 
and miroparticles to form individual aggregates using centrifugation [199, 218].  On the 
other hand, VEGF and gelatin interaction and release could be better controlled by adding 
a binding motif to mediate enhanced binding of VEGF to gelatin; one such binding motif 
is heparin [219-221].  Delivering VEGF bound to heparin stimulates VEGF receptor 
activity [222]. 
Use of a pVE-cadherin GFP reporter ESC cell line allowed for direct and real 
time assessment of VE-cadherin expression and ESC endothelial differentiation during 
embryoid body culture.  Additionally, the GFP reporter cell line provided confirmation of 
the observations and results of similar studies performed using ESCs.  While GFP 
reporter cell lines are useful in confirming results observed when using traditional cell 
lines, when initially performing differentiation experiments in which one is screening for 
general differentiation of ESCs towards the 3 germ layers a specific GFP reporter cell 
linse may not be as useful.  Reporter cell lines that have been transduced with 2 or 3 
plasmids which incorporates multiple promoters associated with different color 
fluorescence proteins, such as pFlk-1 GFP (mesoderm), pPax6 RFP (ectoderm), and 
pAFP YFP (endoderm) may be more useful in quickly assessing differentiation towards 
multiple cell lineages.  Moreover, when looking at differentiated cells which come from 
similar pre-cursors such as endothelial cells and hematopoieic cells or endothelial cells 
and smooth muscle cells this technology would be very beneficial and lead to the design 
of more efficient and sophisticated experiments. 
In chapter 5 the effects of exogenous VEGF on EBs formed from pre-conditioned 
ESCs was examined, while in chapter 6 hypoxic effects on endogenous VEGF production 
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in EBs formed from pre-conditioned ESCs were analyzed.  These studies demonstrated 
that exogenous effects of VEGF and endogenous production of VEGF is modulated by 
pre-treatment of ESCs, respectively.  50 ng/ml of soluble VEGF was delivered to EBs, 
which is the typical quantity used in protocols to differentiate ESCs in monolayers to ECs 
[55, 86].  On the other hand, EBs cultured under normoxic conditions produced on the 
order of 11ng of VEGF per mg of total proteins within the EBs.  Unexpectedly, ESCs 
pre-conditioned with shear stress produced approximately 60 ng of VEGF per mg of total 
proteins produced within the EBs.  This indicates that EBs under hypoxia have the ability 
to produce growth factors such as VEGF on the orders of magnitudes comparable to 
amounts used for differentiation protocols.  In the aforementioned studies, VEGF was the 
only growth factor analyzed, however other growth factors relevant to endothelial 
differentiation and angiogenesis (pro or anti) need to be examined such as IGF, FGF, 
ephrin, TGF-β1, Ang1, and PDGF.   
The hypoxia studies presented in this work cultured EBs at 3% oxygen for 7 days.  
At day 7 formation of primitive vascular structures were observed suggesting that long 
term culture under low oxygen is needed for endothelial network formation.  It still 
remains to be shown whether these structures within the EBs are maintained, become 
more complex or regress after 7 days of hypoxic culture.  Additionally, if these EBs were 
to be cultured at normoxic condition following 7 days of hypoxia culture how would the 
endothelial like cells organize within the EB.  Moreover, if these EBs were allowed to 
aggregate would the primitive vascular structures in each EB connect with other networks 
in surrounding EBs to develop into an intricate complex vascular network.   
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EBs formed from shear pre-conditioned ESCs cultured under hypoxia provide an 
ideal pre-vascularized tissue for numerous tissues.  The ESCs surrounding the primitive 
vascular network can be treated with a prescribed cocktail of growth factors and 
cytokines to yield cardiomyocytes to produce a vascularized cardiac patch.  The presence 
of primitive vasculature may enhance the success of in vivo implantation and efficacy 
when used in an in vivo myocardial infarction model.  On the other hand, these EBs can 
also be implanted into a hind limb ischemia model in order to stimulate angiogenesis. 
Drug screening is typically performed on cells in monolayer prior to testing in 
animal models [223, 224].  However, cells in monolayer are not an accurate 
representation of the in vivo 3D tissue structure.  In order to screen or test drugs more 
accurately 3D cellular aggregates are more representative of in vivo microenvironment.  
Specifically in understanding how different drugs may affect embryogenesis or tissue 
development EBs better represent the embryonic environment compared to ESCs in 
monolayer. The EBs formed from ESCs pre-conditioned with shear cultured under 
normoxia and under hypoxia would be ideal for screening drugs which have implications 
in vascular formation, angiogenesis, vascular defects and cardiovascular diseases. 
All experiments performed in this work used mESCs.  While mESCs are a good 
cell line to use for proof of principle and for initial investigations, similar experiments 
should be performed using hESCs because many differences have been observed between 
human and mouse ESCs[225-227].  Published studies have generally looked at the self-
renewal properties of hESCs in the presence of low shear stresses [228, 229].  Using 
hESCs will provide more insight into feasibility for potential use of fluid shear pre-
conditioning and hypoxia as a method to generate pre-vascularized tissues for 
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regenerative medicine applications.  Generating quantities of hESCs required to perform 
these experiments is a key challenge, which has been hindered by the labor intensive 
culturing methods and lengthy expansion periods for hESCs 
In conclusion, this work has contributed to developing new methods to control 
endothelial differentiation and vasculogenesis within EBs, as well as strategies to 
generate ECs from ESCs.  Fluid shear stress and hypoxic culture represent bioprocessing 
methods which can generate vasculogenic EBs.  Overall, the insights gained from this 
work provide a platform to explore a number of avenues including but not limited to EB 
growth factor production under hypoxia, pre-vascularized stem cell constructs, and 3D 





EMBRYOID BODIES FORMED FROM EMBRYONIC STEM CELLS 
CULTURED ON DIFFERENT MATRICES 
  
Embryoid bodies (EBs) were formed from ESCs cultured on gelatin (control) and 
ESCs cultured on collagen type IV (static) and cultured for 7 days on a 40 RPM rotary.  
EB morphology (Fig.A1. A-F), EB yields (Fig.A1.G) and cross sectional area (Fig. 
A1.H) were examined.  Additionally, endothelial marker genes Flk-1, Flt-1, VE-cadherin, 
and PECAM expression was analyzed during EB differentiation.  EB morphology was 
similar between control and static EB groups at all time points examined (Fig.A1. A-F).  
On day 2, ESCs cultured on gelatin and collagen IV formed similar amounts of EBs (Fig. 
A1.G).   Furthermore, by day 2 the EB cross sectional area distribution of both EB groups 
were comparable (Fig. A1.H).   Analysis of Flk-1 gene expression revealed control EBs 
expressed similar levels of Flk-1 throughout EB differentiation, while static EBs 
expressed varying levels of Flk-1 throughout EB differentiation (Fig. A1.I).  Flt-1 gene 
expression progressively increased from from day 2 to day 7 in control EBs, while Flt-1 
expression in static EBs was variable throughout EB differentiation (Fig. A1.J). Control 
EBs expressed similar levels of VE-cadherin throughout EB differentiation.  VE-cadherin 
expression levels were altered throughout EB differentiation, levels of expression reached 
a maximum at day 4 (Fig. A1.K).   PECAM expression in both control EBs and static 
EBs was variable throughout EB differentiation (Fig. A1.L). Altogther, these preliminary 
results suggested that culturing ESCs on different matrices prior to EB differentiation had 
little effect on EB morphology. However, endothelial marker gene expression analysis 
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revealed that the matrix ESCs were cultured on prior to EB differentiation affects 
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E-CADHERIN AND VE-CADHERIN EXPRESSION IN EMBRYOID 
BODIES FORMED FROM PRE-CONDITIONED EMBRYONIC 
STEM CELLS 
 E-cadherin and VE-cadherin expression in day 7 EBs formed from pre-conditioned 
(static or shear 5 dyn/cm2) ESCs was examined using immunoflourence and confocal 
imaging.   E-cadherin is expressed by undifferentiated ESCs, while VE-cadherin is 
expressed in vascular endothelial cells.  PC Static EBs were negative for VE-cadherin, 
but contained many cells that were E-cadherin positive (Fig. B1.A). Additionally, phase 
images of the same EBs revealed no optically opaque regions within the EB (Fig. B1.B)  
PC Shear 5 EBs contained a few VE-cadherin positive cells which localized to the center 
of the EB and were not positive for E-cadherin (Fig. B1.C). A phase image of the same 
EB reveals localization of E-cadherin negative cells in dark areas of the EB (Fig. B1.D).  
These results suggest that dark areas of EBs formed from shear pre-conditioned ESCs 
contain differentiating ESCs while endothelial-like cells remain localized to the center of 
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MONOLAYER AND EMBRYOID BODY DIFFERENTIATION OF 
FLUID SHEAR STRESS PRE-CONDITIONED EMBRYONIC STEM 
CELLS 
 Following pre-conditioning at either 0 dyn/cm2 (PC static) or 15 dyn/cm2 (PC 
Shear 15), ESCs were cultured as monolayers or as EBs for 4 days.  Pre-conditioned 
ESCs were culture in monolayer on gelatin or as EBs on a 40 RPM rotary orbital shaker. 
Monolayer cultures were initiated by seeding 250,000 cells in 100 mm Petri dish.  EB 
cultures were initiated by seeding 2E6 cells in 100 mm petric dishes.  Cultures were 
maintained for 4 days which is the time point at which monolayer cultures reached 
confluency.  Phase images of monolayers displayed no distinct differences in cell 
morphology between pre-conditioning regimens (Fig. D1. A, B).  Embryoid body 
morphology was also similiar between groups (Fig. D1. C, D).  Analysis of endothelial 
marker genes Flk-1, Flt-1, VE-cadherin, and PECAM revealed differing gene expression 
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